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Abstract 
Background 
Bronchoscopy is a procedure that is used to investigate and treat respiratory conditions and 
disease. Sedation and analgesia are administered during the procedure to reduce the side 
effects of discomfort and cough. The use of sedation and analgesia is cautioned in patients 
with chronic obstructive pulmonary disease (a high-risk respiratory disease), due to the 
perceived increased risk of complications. A review of the associated literature examining 
adult patients’ experiences during flexible bronchoscopy found no qualitative articles on the 
subject. Due to the numerous quantitative survey-based studies, a significant gap in the 
literature was identified; that of the patient experience during bronchoscopy. 
Aim 
The overarching aim of this research was to investigate the experiences of patients 
undergoing bronchoscopy with sedation and analgesia. This investigation was conducted in 
two parts: i) a systematic review of the associated literature and ii) a qualitative study 
involving patients with high-risk respiratory disease. The aim of the systematic review of 
patient experiences during bronchoscopy with sedation and analgesia was to provide a 
synthesis of current information on the subject, highlight best practices in the field, and 
identify gaps in the literature. A qualitative study was then conducted to investigate 
patients' experiences during bronchoscopy with ‘cautious’ sedation and analgesia. The aim 
of this study was to understand the lived experience of patients with high-risk respiratory 
disease who have undergone bronchoscopy.  
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Methods 
A systematic literature review, based on Cochrane methodology, was undertaken to identify 
randomised controlled trials involving adult patients who had undergone fibreoptic 
bronchoscopy with or without sedation. Eight databases were searched (CINAHL, MEDLINE 
Complete, Cochrane, PubMed, Web of Science, EMBASE, PsycINFO, and Scopus. Two 
reviewers independently screened titles and abstracts of the resultant database searches. 
Studies were excluded if they did not include outcome measures that assessed the patient 
experience of the procedure. After screening was completed, two independent reviewers 
then assessed the included studies for quality and extracted the relevant data. Any 
discrepancies between reviewers were then assessed by a third independent reviewer.  
The qualitative interview study was performed using a phenomenological approach, based 
on the descriptive and interpretive writings of van Manen (1990, 1997). Participants (n = 13) 
were interviewed twice using unstructured interviews; the first, two hours post-procedure 
and the second, 1–7 days post-procedure. Interviews were transcribed and then analysed 
using hermeneutic phenomenological reflection (van Manen, 1990). The principal intention 
of hermeneutic phenomenological research is to uncover, examine and reflect upon the 
lived experience.  
Results  
The systematic review identified 19 studies for inclusion. Cochrane’s risk-of-bias tool was 
implemented to identify evidence-based methodological features that are known to 
increase the risk of bias in trials. In a number of studies, assessing for risk of bias was 
problematic due to the number of unclear descriptions of the study methodology, 
particularly in aspects of sequence generation, allocation concealment, and blinding. It 
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should be noted that blinding was not always an option, due to physical differences of 
interventions for treatment and control arms of the included studies. Further, selective 
outcome reporting bias was indeterminable as study protocols were rarely available. Self-
reported patient outcomes included pain, comfort, cough, satisfaction, memory of the test, 
breathlessness, asphyxiation, fear, distress, global tolerance, nausea, dreaming, secretions, 
worst moment of the experience, and willingness to repeat the procedure. Data from five 
studies were published with limited findings represented in bar graphs, and only one study 
author responded to requests for further data. In all studies, data were collected via survey 
using closed-ended questions. Patients were mostly asked to rate outcomes of the 
procedure on various scales, otherwise they were asked dichotomous questions (yes/no 
responses) to determine the existence of any procedural outcomes. Results were published 
as means (with standard deviations) or median scores with or without score ranges. 
In the interview study, themes were identified that included fears such as the participants 
may have lung cancer or the procedure would be distressing. Some participants were fully 
aware during the procedure, which included negative experiences of choking and coughing. 
For several, this was quite traumatic. Some participants were unaware during the 
procedure. Post-procedure participants commonly reported experiences of sore throat, 
cough and aggravation of asthma. However, most participants accepted the negative 
aspects of their experience, regarding them as a necessary evil in order to obtain a diagnosis 
for their respiratory condition. The care and expertise of the bronchoscopy staff, as 
perceived by the participants, helped to offset some of their fears. 
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Conclusions 
The eligible studies in the literature review showed that the risk of bias was more likely to 
be low in most areas except selective outcome reporting. The risk of bias was more likely to 
be unclear in relation to selective outcome reporting due to the general lack of published 
study protocols. Overall, when comparing the participants’ experiences of pain, coughing 
and willingness to repeat the procedure, the studies identified that greater amounts of 
sedation and/or analgesia resulted in subjects reporting fewer negative outcomes. A meta-
analysis was not conducted due to the heterogeneity between studies, namely the varied 
manner in which results were published and the lack of consistency of the outcome 
measures that were reported.  
The qualitative interview study showed that many participants who underwent 
bronchoscopy with cautious sedation experienced awareness during the procedure. Whilst 
the degree of participants’ awareness was variable, more often than not awareness resulted 
in a negative patient experience. This was, for the most part, due to the discomfort of the 
procedure and to the participants’ contextual fears and concerns about their diagnosis. A 
number of recommendations have been made to help manage the patient experience. The 
use of effective communication strategies by healthcare workers throughout the peri-
bronchoscopy procedure could elicit patient fears and aid in resolving these fears. Provision 
of educational material that informs the patient about what to expect from the procedure 
and how it might make them feel may reduce their fears of the procedure as hurtful. In 
addition, medical management of common patient experiences may reduce the extent of 
these experiences. In conclusion, although the use of deeper sedation might ameliorate 
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much of the negative patient experience, this must always be balanced against their risk of 
respiratory complications. 
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Chapter One: Introduction 
1.1 Overview 
The purpose of Chapter One is to provide a rationale for this research that investigates the 
patient experience of bronchoscopy with sedation and analgesia. It begins with a brief 
overview of the bronchoscopy procedure and the administration of sedation before 
focusing on the burden of this condition from the patient perspective. The discussion 
focuses on an ethical opinion of authority. An overview of the literature examining patient 
experience is presented and significant gaps identified. The Chapter concludes with the 
research study aim, objectives, questions, and organisation of this thesis. 
1.2 Delineation of bronchoscopy 
Bronchoscopy is an established diagnostic and interventional procedure for investigation 
and treatment of respiratory conditions and disease. A bronchoscopy enables inspection of 
the lungs via a bronchoscope passed through the nose or mouth into the large airways. It 
also enables the passage of instruments for inspection, sampling and treatments of the 
small airways and surrounding tissue of the lungs.  
1.3 Purpose of bronchoscopy 
Generally, the purpose of bronchoscopy is to either diagnose (diagnostic bronchoscopy) or 
treat (therapeutic bronchoscopy) a respiratory condition. Common indications of respiratory 
conditions are abnormal respiratory symptoms and/or abnormal chest radiology. Abnormal 
respiratory symptoms include: haemoptysis, persistent cough, dyspnoea, stridor, chest pain, 
localized wheeze, persistent chest infection, persistent pneumothorax and hoarse voice 
(Kaparianos, Argyropoulou, Sampsonas, Zania, Efremidis & Spiropoulos, 2008; Saxon, 2012). 
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Abnormal chest radiography includes abnormal lung tissue, enlarged mediastinal nodes, 
collapsed airways and collapsed lungs. The aim of diagnostic bronchoscopy is to diagnose 
respiratory conditions and determine appropriate treatment. This is enabled by the visual 
inspection of the lungs and collection of abnormal tissue from large airways, mediastinum 
and lung peripheries. The aim of therapeutic bronchoscopy is to improve patient morbidity 
in relation to their respiratory condition. Therapeutic bronchoscopy can provide a 
pulmonary toilet (when the patient has a persistent infection), remove foreign bodies, 
debulk tumours, control bleeding, dilate strictures, facilitate insertion of  stents for 
collapsed airways, provide a reduction of excessive lung volume in patients with 
emphysema and reduce increased airway muscularity in patients with uncontrolled asthma 
(Pagana et al., 2017; Saxon, 2012).  
1.4 Contextualization of bronchoscopy patient populations 
Populations of patients who have bronchoscopy differ between various countries and 
studies. Data collected regarding patient characteristics also varies between studies, 
however most studies collect data regarding patient age and gender. A Spanish study 
collected data from 152 patients of which the mean age was 51.9 years and the percentage 
of male participants was 30.9%. In a Swedish study by Grendelmeir et al. (2014) the mean 
age of their 702 patients was 61.5 years and the percentage of males was 57.5%. In a 
Portuguese study by Rolo et al. (2012) the mean age was 56 years and percentage of male 
patients was 66%. According to these studies the age of patients undergoing bronchoscopy 
is trending at over 50 years of age. There does not appear to be a gender trend of more or 
less male patients having the procedure compared to female patients. 
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Some studies have collected data regarding patient indications for the procedure. A 
longitudinal study conducted over 5 years in Greece examined patient indications for 
bronchoscopy in 4,098 cases (Kaparianos et al., 2008). They found that 92% were for 
diagnostic purposes and 8% were performed for therapeutic purposes. They identified four 
common indications for bronchoscopy: haemoptysis (21.1%), fever (19.1%), chronic cough 
(18.2%) and abnormal radiological findings (13.9%). Suspicion of lung cancer was not one of 
the indications listed for bronchoscopy. Signs of lung cancer include: haemoptysis, cough 
and abnormal radiological findings (Cancer Australia, 2012). On their cohort, Grendelmeir et 
al. (2014) found that the indications for bronchoscopy from their patients were suspicions of 
malignancy (25.1%), interstitial lung disease (10.7%), infection (33.8%), chronic cough 
(3.7%), haemoptysis (2.1%), bronchial toilet (10.0%), stenting (2.7%), laser therapy (1.1%) 
and miscellaneous (10.4%). Yoon et al. (2010) conducted a smaller study of 64 patients 
having bronchoscopy in Scandinavia. In their study, the indications for bronchoscopy were 
tumour diagnosis (60.0%), Infection (29.68%), haemoptysis (0.03%) and other (0.1%). It is 
difficult to compare the data collected from these different studies but there appears to be 
a trend towards the following indications: tumour diagnosis, infection, cough and 
haemoptysis. 
Some studies have also collected data regarding patient co-morbidities.  Grendelmeir et al. 
(2014) collected data relating to 14 patient comorbidities ranging from COPD to intravenous 
drug use. The five most common patient comorbidities were solid malignant tumour 
(41.5%), chronic obstructive pulmonary disease (33.6%), Immunosuppression (28.5%), 
coronary artery disease (13.8%) and haematological disease (13.8%). Schlatter et al. (2011) 
collected data from 300 patients regarding 7 possible comorbidities. The five most common 
comorbidities of patients were malignancy (29.7%), immunosuppression (16.7%), COPD 
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(16.3%), diabetes (6.3%) and alcoholism (3.7%). Common co-morbidities between the 
studies were malignancy, immunosuppression and COPD.  
1.5 Procedural description 
Bronchoscopy is often conducted in a specialised suite within a day surgery unit, within a 
theatre, in an endoscopy unit or an intensive care unit. The patient is usually given a topical 
anaesthetic spray to numb the upper airway and sedation to improve comfort. The thin tube 
of the bronchoscopy is then inserted into the airway via the nose or mouth. This often leads 
to the patient coughing, which is addressed by applying more anaesthetic to the patient’s 
vocal cords and throughout the lungs as the bronchoscope passes further into the airways. 
Visual inspection of the airways ceases after inspection of the entrance to each lung lobe 
and the entrances to each lobe segment. If inspection of the mediastinum or peripheral 
areas of the lungs is required, then an ultrasound bronchoscope or ultrasound probe can 
assist in visualisation of the abnormal tissue. Various instruments, including the ultrasound 
probe, can be inserted through the bronchoscope to aid in the collection of specimens or 
treatment of the lungs. The procedure is usually performed within 30 to 45 minutes (Pagana 
et.al., 2017). The length of the procedure is often extended to 60 minutes in the research 
candidate’s centre of practice if it requires the use of ultrasound during bronchoscopy.  
Patients are generally observed after bronchoscopy for at least one hour, after which time 
the patient will usually have recovered from the sedation and oral anaesthetic (AFT 
Pharmaceuticals, 2015; Apotex, 2014; Generic Health, 2014). Recovery from the sedation 
administered during bronchoscopy is dependent on type of sedation administered (Clark et 
al., 2009). Clark et al. (2009) found that propofol was superior to midazolam in shortening 
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recovery time. They found that within 10 minutes of the procedure 90% of the patients in 
the propofol group were alert compared to 50% of the patients from the midazolam group. 
1.6 Bronchoscopy (with or without sedation) 
Typically, during a bronchoscopy, a physician administers sedation and/or analgesia to 
relieve the common procedural side effects of discomfort and cough (Gasparini, 2011). 
Variations in patient tolerance of the procedure have been observed when different 
sedative agents are administered; specifically when stronger sedatives are used that require 
an anaesthetist for administration (Lo et al., 2011). Due to financial deficiencies and staff 
shortages, there may not be an anaesthetist present. This limits the use of stronger sedative 
agents (AFT Pharmaceuticals, 2015), which may improve patient tolerance of the procedure 
(Lo et al., 2011). Without the presence of an anaesthetist, the role of managing a patient’s 
airway becomes the responsibility of a nurse. The nurse supports the patient airway, titrates 
oxygen administration, and works as the patient advocate. As the patient advocate, the 
nurse informs the physician of the patient’s level of sedation and tolerance of the 
procedure. Patient advocacy is a nursing duty according to various nursing codes of ethics 
(International Council of Nurses, 2012; Nursing and Midwifery Board of Australia, 2008). As 
a patient advocate, the nurse is required to protect their patients’ physical, psychological 
and emotional wellbeing (Nursing and Midwifery Board of Australia, 2008). A patient 
advocate is essential for the procedural patient, as the patients are sedated and their 
mouths are obstructed by equipment, which results in an inability to voice their needs.  
1.7 Procedural risk of bronchoscopy 
Physicians are trained to act in the patient’s best interest, and weigh the risks of the 
procedure against the benefits (Medical Board of Australia, 2014; Fifty-seventh World 
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Medical Assembly, 2006). The benefits of performing a bronchoscopy for the patient include 
collecting information that can be used to provide a diagnosis of their respiratory condition 
or disease; this information can then be employed to plan the most fitting, individualised 
health care. The risks associated with the bronchoscopy include hypoxaemia, cardiac 
arrhythmia, pneumothorax, bleeding, fever and infection (Du Rand et al., 2013). The 
bronchoscopy procedure can lead to hypoxia due to the administration of procedural 
sedation and/or analgesia (Apotex, 2014; Generic Health, 2014). Many physicians perceive 
the risk of hypoxaemia as greater when the patient has co-morbidities, such as chronic 
obstructive pulmonary disease (COPD), respiratory failure and/or they are elderly (Du Rand 
et al., 2013). Chronic obstructive pulmonary disease is characterised by a progressive 
irreversible decrease in lung volume (Harris et al., 2010).  All of these co-morbidities are 
commonly associated with hypoxia. As a consequence, the British Thoracic Society 
guidelines for bronchoscopy (Du Rand et al., 2013) recommend giving sedation and 
analgesia ‘cautiously’. However, the British Thoracic Society and the pharmaceutical drug 
companies do not specifically define cautious sedation and analgesia (Du Rand et al., 2013; 
AFT Pharmaceuticals, 2015; Apotex, 2014; Generic Health, 2014). A common sedative 
administered during bronchoscopy is midazolam (Du Rand et al., 2013), which is given to 
promote patient comfort during the procedure and provide a level of amnesia (Du Rand et 
al., 2013; Apotex, 2014). Several studies have demonstrated that physicians underestimate 
patients’ discomfort during bronchoscopy (Hadzri et al., 2010; Putinati, Ballerin, Corbetta, 
Trevisani & Potena, 1999). This may occur in light of the amnesic effect of midazolam 
whereby physicians assume that a patient will not remember the procedure.  
Nursing staff from the research candidate’s centre of practice who have acted as the patient 
advocate during bronchoscopies with ‘cautious’ sedation and analgesia have reported that 
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some patients’ behaviour was symptomatic of suffering. Anecdotally, nurses perceived 
patients as suffering when they repeatedly coughed, gagged and/or attempted to remove 
the bronchoscope before the procedure was completed. When this occurred, nurses 
intervened by comforting the patient and talking them through the procedure.  
There has been no study in the research candidate’s centre of practice regarding the 
prevalence of this patient behaviour and/or the burden of this behaviour on the patient or 
health care centre. Within the current literature, it has been reported that physician- and 
patient-reported tolerance of the procedure increased with sedation (Cases Viedma et al., 
2010; Contoli et al., 2013). It has also been found that physicians may underestimate patient 
discomfort during the procedure (Palayew et al., 2004). In regards to burden of this 
behaviour, Cases Viedma et al. (2010) found that the sedation shortens length of the 
procedure and Contoli et al. (2013) found that the absence of sedation did not increase the 
diagnostic yield from the procedure.   
Berglund, Westin, Svanström & Sundler (2012) found that patients experienced suffering in 
health care when their feelings were ignored, resulting in feelings of vulnerability and 
powerlessness. At the research candidate’s centre of practice, nurses’ observations of 
patients during bronchoscopy with cautious sedation and analgesia has raised a number of 
questions. Key questions included: Do the patients feel that their feelings during the 
procedure are ignored by the staff; if patients were under sedation during a bronchoscopy, 
were their coughing, gagging and attempts to remove the bronchoscope conscious or 
unconscious behaviour; could the patients recall their behaviour following the procedure; 
and what impact did this behaviour have on the patients following the procedure? 
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1.8 Ethical opinion of authority 
In a discussion paper concerning bronchoscopy and sedation (Gasparini, 2011), it was 
suggested that patients should undergo this procedure without discomfort. Gasparini (2011) 
summarised several studies that had trialled variations in drugs commonly administered 
during bronchoscopy. In the study by Clark et al. (2009) patients reported that propofol 
provided increased rates of patient tolerance, and reduced rates of pain, breathlessness and 
nausea during the procedure when the sedative was compared to midazolam. However, 
propofol manufacturers recommend that it should only be administered by an anaesthetist 
due to the associated risks of respiratory depression (AFT Pharmaceuticals, 2015), which 
may cause hypoxia. This can be problematic in many endoscopy settings where procedures 
are conducted without an anaesthetist present, such as the research candidate’s centre of 
practice. 
1.9 Evidence of patient experience in bronchoscopy 
Wolf, Niederhauser, Marshburn & LaVela (2014) provided a 14-year synthesis of existing 
literature used to define patient experience. Their literature review found 18 sources with 
no common definition for patient experience in health care. The various definitions were 
based on similar elements: interaction, culture, perception and continuum of care. As the 
basis of their enquiry into a definition for patient experience, Wolf et al. (2014) 
acknowledged and used The Beryl Institute’s website’s (n.d.) current definition for patient 
experience: 
The sum of all interactions, shaped by an organization’s culture, that 
influence patient perceptions across the continuum of care.  
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Based on this definition, a search of the literature found several studies that measured 
patient perceptions of their experience during bronchoscopy with sedation and/or analgesia 
(Contoli et al., 2013; Palayew et al., 2004; Rolo et al., 2011). Patient perceptions were 
measured by asking each patient to evaluate specific outcomes of their interaction with the 
medication, equipment, staff and procedure (Bernascoi et al., 2009). However, the study 
outcomes and scales used to measure these outcomes varied between the different studies.  
Hong, Choi, Park & Park (2015) performed a systematic review of randomised controlled 
trials that assessed the efficiency and safety of moderate sedation during flexible 
bronchoscopic procedures. The main aim of the review was to examine the efficiency of 
bronchoscopy under moderate sedation. Efficiency was measured by comparing patient 
willingness to repeat the procedure, procedure time, and patient experiences of pain and 
cough. The willingness of the subjects to repeat the procedure was examined in six studies, 
the data were pooled and it was found that sedated patients were significantly more willing 
to repeat the procedure than those who were not sedated (p = 0.02). Hong et al. (2015) 
pooled data from 3 studies that measured the length of the procedure when the patient 
received midazolam compared to when they received a placebo; length of the procedure 
was shorter when the patient received midazolam as sedation (p = 0.02). In three studies, 
where patients were given sedation or a placebo, the subjects self-reported their 
experiences of pain and cough, in two of these studies the subjects’ experiences of pain (p < 
0.01, p < 0.001) and cough (p < 0.05, p < 0.001) were significantly reduced in the sedated 
group. The third study used a different scale to measure patient experience of pain and 
cough so the results were not pooled for a meta-analysis (Hong et al., 2015).  
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Other patient experiences measured during bronchoscopy not included in the systematic 
review by Hong et al. (2015) were amnesia, distress, anxiety, breathlessness and choking 
(Cases Viedma, Pérez Pallarés, García, Reyes, Moret & Aldás, 2010; Gonzalez, De-La-Rosa-
Ramirez, Maldonado-Hernandez & Dominguez-Cherit, 2003; Rolo et al., 2012). Summarising 
other self-reported patient experiences during bronchoscopy in a literature review may 
provide health care workers with more insight regarding patient experience. In addition, 
Hong et al. (2015) compared patient experience in bronchoscopy with sedation versus 
placebo; a systematic review that compared different sedative drugs would provide more 
evidence for best practice.  
To date, no qualitative studies have explored the patient experience in bronchoscopy with 
sedation and analgesia. Using qualitative methodology, the data are collected from the 
person who has first-hand experience of the phenomenon, in this case bronchoscopy 
(Chandler & Munday, 2011). Furthermore, the person’s own reflections or perceptions of 
their experience of a phenomenon have been described as their ‘lived experience’ (Chandler 
& Munday, 2011). It was determined that a qualitative exploration of patients’ ‘lived 
experience’ during bronchoscopy under sedation and analgesia may: i) identify how 
coughing, distress and choking can affect a patient during the procedure; and ii) uncover 
unexpected problems that could be ameliorated with appropriately planned health care. 
1.10 Overall research question, aims and objectives 
The research question to be addressed is: 
What is the patient experience of bronchoscopy with sedation and analgesia, particularly 
those with high-risk respiratory problems that require ‘cautious’ sedation and analgesia? 
The aim of this research was two-fold: 
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i) to identify the patient experience during bronchoscopy with sedation and analgesia 
and  
ii) to provide recommendations to inform best practice. 
The specific objectives are to: 
● review current literature regarding patient experience in bronchoscopy to identify 
gaps and best practice;  
● explore the lived experience of patients with high-risk respiratory disease that 
undergo bronchoscopy with ‘cautious’ administration of sedation and analgesia; 
●  recommend risk management procedures to manage the negative patient 
experience that may occur during bronchoscopy with cautious sedation and 
analgesia; 
● provide recommendations for the development of pre-procedural educational 
material; and 
● provide recommendations for the development of an assessment tool to measure 
patient tolerance/satisfaction during bronchoscopy. 
 
1.11 Organisation of the thesis  
This master’s thesis explores the patient experience of bronchoscopy. Chapter Two reviews, 
collates and synthesises the associated literature on this subject. Chapter Three explores 
patients’ perception of their experience in bronchoscopy within the context of a qualitative 
research study. In Chapter Four, the study discussion and conclusions are presented, 
providing insights into patient experience and recommendations for patient care and future 
– 12 – 
 
research. Appendix 1 contains a protocol for a systematic review on the subject of patient 
experience in bronchoscopy.  
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Chapter Two: Literature Review 
2.1 Overview 
The purpose of Chapter Two is to explore the literature relating to patients’ experience of 
bronchoscopy. Components of this chapter include a rationale of why this topic was chosen, 
the research question and objectives, the methods based on Cochrane systematic review 
methodology, findings of the review, a synthesis of the findings and the conclusion.  
2.2 Introduction 
On investigation of the literature relating to patient experience in bronchoscopy, no 
qualitative studies were found that explored the patient experience whilst undergoing 
bronchoscopy. The literature search was expanded to include quantitative studies on the 
subject. It was found that many countries reviewed quantitative studies on the subject and 
then formulated national guidelines for patient management in bronchoscopy (Du Rand, et 
al., 2013; Shulimzon, 2010; Wahidi et al., 2011; Wood-Baker, Burdon, McGregor, Robinson 
& Seal, 2001). Within these guidelines, a common theme relating to patient experience was 
found: bronchoscopy is an uncomfortable procedure without sedation and/or analgesia. The 
foundation of this theme was based on several randomised controlled trials, which 
concluded that patients’ comfort was improved with sedation and/or analgesia (Gonzalez et 
al., 2003; Putinati et al., 1999; Stolz, et al., 2004). In these trials, patients were asked to 
measure various aspects of their experience, which included amnesia, tolerance, pain, 
cough, choking, and willingness to repeat the procedure. To ensure a rigorous search of the 
literature, Cochrane methodology (Higgins & Green, 2011) was followed, and a literature 
review question, aims and objectives were formulated. 
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2.3 Research question, aims and objectives 
The aim of this literature review was to explore the experiences of adult patients 
undergoing bronchoscopy. The research question for this literature review was framed so 
that the data collected could be generalised to the research candidate’s institution of 
practice (adult patients undergoing fibreoptic bronchoscopy with various types and levels of 
sedation) and therefore be used in ongoing development of evidence-based nursing care. 
The research question was formulated using an evidence-based medicine process: 
population, intervention, comparison, outcome, study design (PICOS). PICOS is a systematic 
method of framing a research question to most accurately define the clinical problem 
(Liberati et al., 2009). The components of the acronym PICOS and their application are 
illustrated in Table 1. 
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Table 1: Components of PICOS 
Components Description Application 
Patients Patients involved in the clinical 
problem 
Adult patients undergoing flexible 
bronchoscopy 
Interventions Interventions that can be used to 
ameliorate this problem 
Randomised procedural sedative 
administration 
Comparison Additional interventions that can be 
compared to reduce the problem 
Sedative +/- pre-medication or 
placebo 
Outcome  Scales or tools that provide 
evidence that the problem has been 
minimised  
Patient experience/satisfaction 
Study design Study design chosen Randomised controlled trials 
 
With this in mind the research question was defined as: 
What is the adult patient experience of flexible bronchoscopy with sedation 
and/or analgesia using evidence from randomised controlled trials? 
The endpoint of this review was to promote best practice, and/or identify gaps in the 
current literature. Therefore the objectives for this literature review were to: 
 identify data relating to patient experience during bronchoscopy with sedation and 
analgesia 
 provide a synthesis of the data collected, highlighting data relating to best practice and 
any gaps in the current evidence. 
– 16 – 
 
 2.4 Methods 
The methodology used to conduct the review was based on recommendations from 
Cochrane (Higgins & Green, 2011), which includes problem identification, literature search, 
data evaluation, data analysis, data reduction, comparison, conclusions and presentation. 
On completion of the review of the associated literature, no studies were found that 
focused specifically on the patient’s experience of bronchoscopy. There were, however, 
over 500 studies relating to the subject of bronchoscopy and patient satisfaction. In these 
studies, patients were asked to rate their perceptions of different aspects of their 
procedure. Often these studies asked patients whether they were bothered or not by 
various aspects of the procedure, including anaesthetic spray, scope insertion, shortness of 
breath, and physician manner and skill (Hirose et al., 2008; Lechtzin, Rubin, White, Jenckes 
& Diette, 2002). Thus, this information was extracted to identify the ‘patient experience’. To 
promote rigour and a high level of evidence, the literature review used a systematic method 
(Higgins & Green, 2011) to review randomised controlled trials that measured outcomes 
relating to patient experience in bronchoscopy. The review was registered with the 
Prospero International prospective register of systematic reviews as ‘a systematic review of 
adult patients’ experiences during flexible bronchoscopy with placebos and/or various 
pharmaceutical agents’ (publication: CRD42016037583; see Appendix 1). 
2.4.1 Data sources 
Studies were identified using the databases CINAHL, MEDLINE Complete, Cochrane, 
PubMed, Web of Science, EMBASE, PsycINFO and Scopus. The search terms included the 
population (adult patients undergoing flexible bronchoscopy by either oral or nasal route), 
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intervention (randomised procedural sedative administration) and possible comparators 
(usual care/placebo vs other sedatives and/or analgesics). See the search terms below: 
Bronchoscopy AND (fentanyl OR dormicam OR hypnovel OR flunitrazepam 
OR benzodiazepine OR lignocaine OR dextromethorphan OR midazolam OR 
lidocaine OR prilocaine OR lorazepam OR “nitrous oxide” OR ketamine OR 
alfetanil OR fospropofol OR disodium OR alfentanil OR propofol OR 
dexmedetomidine OR remifentanil OR hypnotics OR sedatives OR sedation 
OR hypnotics OR conscious sedation) 
The search was restricted to English language publications, as there was no funding for 
translation of non-English language publications. The references were uploaded to the 
Covidence website (https://www.covidence.org/), which is the primary screening and data 
extraction tool for the Cochrane Community (2017). It enabled two authors to 
independently screen study titles and abstracts (Saxon and Fong) and another researcher to 
resolve discrepancies (Ski). The full texts of the remaining studies after the initial screen 
were then uploaded to the Covidence website so that two authors (Saxon and Fulbrook) 
could independently select studies that met the literature review criteria. The discrepancies 
from the full-text screening were then resolved through discussion between two 
researchers.  
2.4.2 Study selection/screening 
The study selection criteria were based on each study’s method, population, comparators, 
setting, outcome measures and age. Only studies that presented as randomised controlled 
trials were selected. The populations of these studies included only adult patients 
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undergoing flexible bronchoscopy by either oral or nasal approach. Studies with the 
following patient populations were excluded: patients undergoing rigid bronchoscopy, 
children, non-humans, ventilated patients, non-invasive ventilation patients, spinal injury 
patients, and patients with cognitive impairment. The comparators included usual 
care/placebo versus other sedatives/sedative + other pharmaceutical agents +/- 
premedication. Possible sedatives and analgesia included fentanyl, dormicam, hypnovel, 
flunitrazepam, benzodiazepine, midazolam, lorazepam, nitrous oxide, ketamine, alfetanil, 
fospropofol disodium, alfentanil, propofol, dexmedetomidine, remifentanil. The selected 
settings were day surgery units, hospital procedure rooms or theatres. All studies conducted 
in intensive care units were excluded. Studies were required to include outcomes that 
involved patients’ self-reports of their experience of bronchoscopy, for example comfort, 
cough, pain, anxiety, distress and/or fear. An acceptable reported secondary outcome was 
willingness to repeat the procedure. These outcomes were measured with visual analogue 
scales/ Likert scales or yes/no answers on surveys. The measures were assessed post-
procedure, when the patient was fully awake.  
The age of the study was restricted to those published after 2001. In 2001, the British 
Thoracic Society was the first to introduce guidelines related to the use of sedation during 
bronchoscopy (British Thoracic Society Bronchoscopy Guidelines Committee, 2001). These 
guidelines recommend that sedation should be offered to patients to improve their comfort 
and tolerance of the procedure, if there are no contraindications. The guidelines also 
recommend that sedation should be administered in incremental doses to prevent 
complications whilst promoting adequate sedation and amnesia. These guidelines are used 
in the research candidate’s place of practice.  
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2.4.3 Data extraction 
Within the Covidence online software, two authors independently extracted data from the 
included studies. The data extracted were study method quality, population, interventions 
and data from outcomes. Covidence uses the Cochrane risk-of-bias tool to establish the 
quality of study methods used to perform the randomised controlled trial. Each study 
method was judged as high/low or unclear in relation to randomisation, concealment, 
blinding, completeness of data collected, any incidence of selective outcome reporting, and 
other sources of bias. 
2.4.4 Data analysis and synthesis 
When meta-analysis of the patient-reported outcomes was considered, it was found that 
the retrieved studies were heterogenous in both the medications they compared and the 
outcomes that were measured.  Due to the heterogenous nature of the selected studies, it 
was not appropriate to pool data for a meta-analysis. Thus, a narrative synthesis of the 
outcome data was conducted, to expose statistical differences between comparative 
populations in each study. 
2.5 Results 
The initial literature search identified 558 studies. No further studies were identified 
through other sources. After the initial literature search, the studies were uploaded using 
the Covidence™ online software. Fifty four duplicates were subsequently identified. The 
remaining titles and abstracts were then screened for relevance. Three hundred and nine 
studies were excluded because they did not meet the selection criteria. The full texts of 95 
studies were then screened. A further 76 studies were excluded as they were published 
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prior to 2001, were a duplicate, were not a full study report, were not published in English, 
or used incompatible  methods; in particular: outcomes did not include self-reported patient 
experience; comparators did not include a sedative; study was not randomised; or the 
sample was not adult or human.. The PRISMA diagram in  
Figure 1 shows the flow of studies through the study selection process. 
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Figure 1: A review of adult patients’ experiences during flexible bronchoscopy with placebos and/or various 
pharmaceutical agents PRISMA 2009 Flow Diagram 
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The studies included in the anaylsis (n = 15), were conducted in a variety of countries from 
Brazil to United Kingdom, and across a range of facilities including single or multiple centres, 
endoscopy units, hospitals, main operating theatres, and bronchoscopy suites. Sample sizes 
ranged from 18 to 702 participants. The mean age of patients ranged from 40 to 81 years. 
There were generally greater numbers of males than female subjects  in all but two of the 
studies. Indications for the procedure were documented in nine studies; common 
indications were infection, suspected malignancy, staging of lung cancer, endobronchial 
obstruction, haemoptysis and chronic cough. Patient co-morbidities were identified in six 
studies, the data collected varied between studies and included the incidence of COPD, 
cardiovascular disease, diabetes, liver disease, tuberculosis, aquired immune deficiency 
syndrome, alcohol and/or drug abuse. All studies were randomised controlled trials with 
adult subjects. The pharmaceutical intervention was varied across the studies (see Table 2).  
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Table 2: Systematic review study characteristics 
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Quality assessment of the trials was conducted to evaluate if flaws in the study methods 
could have led to underestimation or overestimation of the effect of the study intervention 
(Higgins, et al., 2011). To ensure a systematic assessment of each study’s methods, two 
authors independently assessed all 19 studies for risk of bias in their methodology (see 
Table 3). After quality assessment, it was found that no study had a clear record of avoiding 
the risk of bias across all potential sources of bias in their methodology. The area of least 
risk of bias within the group of studies was the completeness of outcome data presented. 
However, the area where methods bias was most unclear was the area of selective outcome 
reporting. The area with the greatest risk of bias was blinding of participants and personnel. 
Outcome data collection was reported in a variety of ways, which made comparisons 
difficult. Five studies provided numbers (sum) or percentages in relation to patients’ 
response to Likert scales, visual analogue scales and polar (dichotomous) questions (Atassi 
et al., 2005; Gonzalez et al., 2003; Houghton et al., 2004; Rolo et al., 2012; Silvestri et al., 
2009). Five studies presented outcome data from Likert scales and visual analogue scales as 
means alone or with standard deviation or ranges (Cases Viedma et al., 2010; Clark et al., 
2009; Hwang et al., 2005; Schwarz et al., 2007; Watts et al., 2005); two studies presented 
outcome data from visual analogue scales as medians with interquartile ranges 
(Grendelmeier et al., 2014; Schlatter et al., 2011); six studies presented outcome data from 
a Likert scale survey and visual analogue scales in graphs (Contoli et al., 2013; de Padua et 
al., 2004; Korteweg et al., 2004; Lo et al., 2011; Ryu et al., 2012; Yoon et al., 2011), and one 
study only reported on significant differences between intervention groups (Liao et al., 
2012). Six authors were contacted with a request for further data. Two authors responded 
after the second email, one of whom responded by sending appropriate data (Contoli et al., 
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2013). The only consistent outcome data, which were presented across all studies, were the 
results of significant difference testing between treatment groups (p values). Therefore, the 
outcome data tables (Tables 4–6) present p values to illustrate the significant differences 
between treatment groups. 
The data tables (Tables 4–6) also include the various outcomes reported, however there was 
no consistency across the studies in either the outcomes assessed, the measures used to 
assess outcomes, or the manner in which the results were reported. For example, Likert 
scales were reported as mean and standard deviation (Cases Viedma et al., 2010), 
percentages (Silvestri et al., 2009), or graphically (Contoli et al., 2013). There were three 
studies that compared midazolam to a placebo, but the doses of midazolam were not 
consistent between the studies however all the studies reported that with larger doses of 
midazolam subjects evaluated the procedure more favourably. Two of these studies also 
reported on the patient experience of coughing however outcome data collection was 
variable. In one study participants were asked to identify their main complaint (of which 
cough was an option) and the other participants were asked to evaluate their experience of 
coughing during the procedure using a visual analogue scale. 
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Table 3: Quality assessment of included studies 
1st Author
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Atassi (2005) Low Low Low Unclear Low Unclear Low
Cases Viedma (2010) Low Unclear Low Low Low Unclear High
Clark (2009) Unclear Low Low Low Low Low Low
Contoli (2013) Low Low Low Low Low Unclear Unclear
dePadua (2004) Unclear Low Low Unclear Unclear Unclear Low
Gonzalez (2003) Unclear Unclear High Low Low Low Low
Grendelmeier (2014) Low Unclear High Low Low Low Low
Houghton (2004) Low Low Low Low Low Unclear Unclear
Hwang (2005) Unclear Low Low Low Low Unclear Low
Korteweg (2004) High High High Unclear Low Unclear High
Liao (2012) Low Unclear High Unclear Low Low High
Lo (2011) Low High High Low Low Low High
Rolo (2012) Unclear Unclear Unclear Unclear Unclear Unclear Low
Ryu (2012) Unclear Low Low Low Low Low Low
Schlatter (2011) Low Low Low Low Low High Low
Schwarz (2007) Unclear Low Low Low Unclear Unclear Low
Silvestri (2009) Unclear Unclear Low Unclear Low Low Low
Watts (2005) Unclear Unclear Low Unclear Low Unclear Low
Yoon (2011) Low Low Low Unclear Low Unclear Low  
Low Low risk of bias comparison between treatment groups
Unclear Unclear risk of bias comparison between treatment groups
High High risk of bias comparison between treatment groups
Colour codes
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Table 4: Outcome data table—midazolam studies 
Amnesia Dreaming
Distress during test / 
Anxiety
Patient 
tolerance score
Pain / 
discomfort
Nasal pain / 
discomfort
Soreness in 
throat
Anaesthetic 
inhalation
Scope 
insertion Comfort Cough Breathlessness Nausea Choking Satisfaction
Repeat similar 
procedure 
Cases 
Viedma 
(2010)
Midazolam (0.07-
0.1mg/Kg) vs placebo 152
0.0001 0.001 0.0001 0.0001 0.0001 0.002
Contoli 
(2013)
Midazolam (0.035mg/kg) 
vs placebo 67
NS
Contoli 
(2013)
Midazolam (0.07mg/Kg) 
vs Midazolam 
(0.035mg/kg) 67
NS
Contoli 
(2013)
Midazolam (0.07mg/Kg) 
vs placebo 66
<0.01 t5r0p
Houghton 
(2004)
Alfentanil (0.95mg) vs 
Midazolam (4.2mg) 46
0.13 0.31 0.76 vcccb
Liao (2012)
Midazolam (5.8mg)vs 
Dexmedetomidine 
(66.2mcg) 197
NS <0.001 NS
Rolo (2012)
Midazolam (2.56mg) vs 
placebo 100
NS 0.017 0.002 0.03 <0.001 NS 0.003
Schwarz 
(2007)
Midazolam (3.1mg) 
/Dextromethorphan 
(90mg) vs Midazolam 
(4.2mg)/placebo 59
<0.005 0.00005 <0.05
First Author 
(year)
Drugs used for 
sedation/analgesia
Psychological Physical Satisfaction
P
o
p
u
la
ti
o
n
 s
iz
e
Each of the studies compared patient experience outcome data between their treatment and control groups. Each study reported if there was a significant difference between the groups outcome values and presented this data as a p values. A p value was considered significant, when it was less than 0.05.  Not all studies reported p values if they did not consider the value 
significant. All of the studies did not collect data for all of the outcomes listed on this table. If no data was collected for an outcome then the corresponding box is shaded yellow. If data collected for the outcome was not significant then the corresponding box is shaded red. If the data collected for the outcome was significantly different between the treatment group and the 
control group then the corresponding boxes are shaded green and the p value is displayed (the treatment group is always listed fired first in the "Drug used for sedation/analgesia" column). vs = versus, mg = milligram, BMI = body mass index, NS = not significant  
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Table 5: Outcome data—Propofol studies 
Amnesia Dreaming
Distress during test / 
Anxiety
Patient 
tolerance score
Pain/ 
discomfort
Nasal 
discomfort
Lung pain/ 
discomfort
Anaesthetic 
inhalation
Scope 
insertion Comfort Cough Breathlessness Nausea Choking Satisfaction
Repeat similar 
procedure 
Clark (2009)
Propofol (135.1mg) vs 
Midazolam (6.2mg) 82
0.051 0.026 0.946 0.024 0.047
Lo (2011)
Propofol 
(198.6mg)/Alfentanil 
(325.4 mcg) vs 
Midazolam 
(6.8mg)/Alfentanil 
(350.3mcg) 460
<0.001 0.138 0.084 0.012 0.026 0.018
Gonzalez 
(2003)
Propofol (133mg) vs 
placebo 18
<0.0001 <0.01 <0.01 <0.05 <0.001 <0.01
Grendelmeie
r (2014)
Propofol infusion 
(308.3mg) vs Propofol 
bolus doses (226.6mg) 702
0.737 0.942 0.917 0.288
Hwang 
(2005)
Propofol 
(28.1mg)/Ketamine 
(14.0mg) vs Propofol 
(28.2)/Alfentanil 
(282mcg) 276
<0.01 <0.01 <0.05 NS
Ryu (2012)
Propofol 
(2.8mcg/kg/min) 
/Remifentanil 
(2.9mcg/kg/min) vs 
Propofol 
(2.37mcg/kg/min) 
/dexmedetomidine 
(1.0mcg/kg/min) 70
NS NS
Schlatter 
(2011)
Propofol  (200mg) 
/hydrocodone (4mg)vs 
Propofol (260mg) 
/placebo 
(inspection/washings) 100
0.992 0.899
Schlatter 
(2011)
Propofol  (200mg) 
/hydrocodone (4mg)vs 
Propofol (260mg) 
/placebo (additional 
specimens) 200
0.016 0.036
Schlatter 
(2011)
Propofol  (200mg) 
/hydrocodone (4mg)vs 
Propofol (260mg) 
/placebo 300
0.037 0.025
Silvestri 
(2009)
Fospropofol 
(6.5mg/kg)/Fentanyl vs 
Fospropofol 
(2mg/kg)/Fentanyl 252
<0.01 NS NS <0.01
Yoon (2011)
Propofol (43.6mg) 
/alfentanyl (435.7mcg) vs 
Propofol (46.2mg) 
/placebo 64
NS NS
Psychological Physical Satisfaction
First Author 
(year)
Drugs used for 
sedation/analgesia
P
o
p
u
la
ti
o
n
 s
iz
e
Each of the studies compared patient experience outcome data between their treatment and control groups. Each study reported if there was a significant difference between the groups outcome values and presented this data as a p values. A p value was considered significant, when it was less than 0.05. Not all studies reported p values if they did not consider the value 
significant. All of the studies did not collect data for all of the outcomes listed on this table. If no data was collected for an outcome then the corresponding box is shaded yellow. If data collected for the outcome was not significant then the corresponding box is shaded red. If the data collected for the outcome was significantly different between the treatment group and the 
control group then the corresponding boxes are shaded green and the p value is displayed (the treatment group is always listed fired first in the "Drug used for sedation/analgesia" column). vs = versus,  mcg = microgram, mg = milligram, BMI = body mass index, NS = not significant.  
                               
 
– 36 – 
 
Table 6: Outcome data—other drug studies 
Amnesia Dreaming
Distress during 
test/Anxiety
Patient 
tolerance score
Pain/  
discomfort
Nasal pain/ 
discomfort
Lung pain/ 
discomfort
Anaesthetic 
inhalation
Scope 
insertion Comfort Cough Breathlessness Nausea Choking Satisfaction
Repeat similar 
procedure 
Atassi (2005)
Nitrous oxide 9-12 L/min 
vs placebo 205
<0.05 <0.01 <0.05 NS
De Padua 
(2004)
Clonidine (3mcg/kg) vs 
placebo 42
NS
Korteweg 
(2004)
Atropine (0.5mg) 
/Codeine (20mg) vs 
Codeine (20mg) 124
0.035
Korteweg 
(2004)
Atropine(0.5mg) 
/Codeine (20mg) vs 
placebo 132
0.0004 0.05
Korteweg 
(2004)
Codeine (20mg) vs 
Ipratropium bromide 
(0.5mg) 126
0.843
Korteweg 
(2004)
Ipratropium bromide 
(0.5mg) vs placebo 134
0.352 0.585
Korteweg 
(2004)
Codeine (20mg) vs 
placebo 160
0.404 0.044
Watts (2005)
Temazepan (10mg) 
nebulised lignocaine 
(4ml/2%) vs Alfentanyl 
(BMI <23, 250mcg, 
BMI>23 500mcg) 50
0.019 0.013
Each of the studies compared patient experience outcome data between their treatment and control groups. Each study reported if there was a significant difference between the groups outcome values and presented this data as a p values. A p value was considered significant, when it was less than 0.05. Not all studies reported p values if they did not consider the value 
significant. All of the studies did not collect data for all of the outcomes listed on this table. If no data was collected for an outcome then the corresponding box is shaded yellow. If data collected for the outcome was not significant then the corresponding box is shaded red. If the data collected for the outcome was significantly different between the treatment group and the 
control group then the corresponding boxes are shaded green and the p value is displayed (the treatment group is always listed fired first in the "Drug used for sedation/analgesia" column). vs = versus,  L= litre, mcg = microgram, mg = milligram, BMI = body mass index, NS = not significant.
First Author 
(year)
Drugs used for 
sedation/analgesia
P
o
p
u
la
ti
o
n
 s
iz
e
Psychological Physical Satisfaction
 
 
 
 
                               
 
– 37 – 
 
The psychological and physical outcomes were assessed using various response formats 
including visual analogue scales, Likert scales and dichotomous questions. Patient 
satisfaction outcome data were predominately measured with visual analogue scales and by 
measuring participants’ willingness to repeat a similar procedure, with visual analogue 
scales or a dichotomous response. The most common outcomes that were measured were 
pain, cough and willingness to repeat the procedure. Dreaming, lung pain, anaesthetic 
inhalation discomfort and choking were each measured only once across the 19 studies. 
Outcome data were reported inconsistently. 
Psychological outcomes that were assessed were amnesia, dreaming, tolerance, distress, 
and anxiety. The studies concluded that the degree to which participants rated these 
outcomes was related to the type and level of sedation or analgesia administered. 
Significant differences in amnesia (p < 0.01), anxiety (p = 0.001) and patient tolerance (p = 
0.026) were found when sedation was compared to a placebo (Cases Viedma et al., 2010; 
Gonzalez et al., 2003; Schwarz et al., 2007). When the analgesic ketamine was added to 
propofol and compared to the analgesic alfentanyl and propofol, ketamine provided 
significantly higher ratings of amnesia (p < 0.01) and dreaming (p < 0.01) with minimal 
respiratory effects (Hwang et al., 2005). When high doses of fospropofol (6.5mg/kg) with 
fentanyl were compared to low dose fospropofol (2mg/kg) with fentanyl, there were 
significantly greater ratings of amnesia (p < 0.01) (Silvestri et al., 2009). When a propofol 
infusion was compared to propofol bolus delivery, there were no significant differences in 
participants’ ratings of anxiety (p = 0.737) (Grendelmeier et al., 2003). When a low dose 
midazolam (0.035mg/kg) was compared to a placebo, no significant differences were 
reported in patient tolerance (Contoli et al., 2013). When lower doses of midazolam 
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(0.035mg/kg) were compared to higher doses of midazolam (0.075mg/kg), there was no 
difference in the patients’ reported procedural tolerance. However, when the higher-dose 
midazolam (0.075mg/kg) was compared to a placebo, there was a significantly higher level 
of tolerance (p < 0.01) in the sedated group (Contoli et al., 2013). Propofol was more 
tolerable than a placebo (Gonzalez et al., 2003), and propofol alone was more tolerable (p = 
0.051) than midazolam alone (Clark et al., 2009; Lo et al., 2011). 
The studies examined patient reports of several physical outcomes: pain/discomfort, 
breathlessness, and choking. There were significantly higher ratings of the physical 
outcomes when non-sedated participants were compared to sedated participants (Atassi et 
al., 2005; Cases Viedma et al., 2010; Gonzalez et al., 2003; Schwarz et al., 2007; Watts et al., 
2005). The sedative midazolam worked significantly better than a placebo at reducing 
participants’ ratings of pain (p < 0.001; < 0.001), cough (p < 0.001; < 0.05) and 
breathlessness (p < 0.001) (Cases Viedma et al., 2010; Schwarz et al., 2007). Rolo et al. 
(2012) collected outcome data regarding patients’ worst moments during the procedure 
and their main complaint regarding the procedure. They reported that there were 
significant differences between the sedated group and placebo group when patients were 
questioned if their worst moment was the passage of the bronchoscope through the vocal 
chords (p = 0.017) and if they had no worst moments (p = 0.002). It was theorised that this 
occurred due to amnesia of the procedure; unfortunately amnesia was not measured in this 
study. Rolo et al. (2012) also asked the patients which of the following potential side effects 
of the procedure was their main complaint: nausea, cough, dyspnoea and pain. There were 
significantly more complaints of cough (p = 0.03) and dyspnoea (p < 0.001) in the placebo 
group. This did not mean that patients did not complain of pain (8%) only that there was no 
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difference in this outcome between the patients in the sedated and placebo group.  The 
sedative nitrous oxide also worked significantly better than a placebo in relieving pain (p < 
0.05) and cough (p < 0.01) (Atassi et al., 2005). When the sedative temazepan was 
compared to alfentanil, the temazepan group rated their level of discomfort lower than that 
of the alfentanil group (p = 0.019) (Watts et al., 2005). There was no significant differences 
in relation to participants’ pain (p = 0.13), nasal discomfort (p = 0.31) or throat soreness (p = 
0.76) ratings when alfentanil was compared to midazolam (Houghton et al., 2004). When 
clonidine usage was compared to a placebo, there was no significant difference in 
participants’ ratings of comfort (significance not reported) (de Padua et al., 2004). When 
participants sedated with propofol were compared to participants sedated with midazolam, 
propofol significantly reduced participants’ ratings of pain (p = 0.051), breathlessness (p = 
0.024) and nausea (p = 0.047) (Clark et al., 2009). When propofol with alfentanil was 
compared to midazolam with alfentanil, the propofol group rated better for scope insertion 
discomfort (p = 0.012), cough (p = 0.026) and breathlessness (p = 0.018) (Lo et al., 2011). 
When bolus dose propofol was compared to propofol infusion, there was no significant 
difference in participants’ ratings of discomfort (p = 0.942) or cough (p = 0.917) 
(Grendelmeier et al., 2014). 
Participants’ willingness to repeat the procedure under the same circumstances was 
significantly higher in patients who were sedated with midazolam (p = 0.002; 0.003), 
propofol (p < 0.01) and temazepan (p = 0.013) than in patients who were given a placebo 
(Cases Viedma et al., 2010; Gonzalez et al., 2003; Rolo et al., 2012; Watts et al., 2005). There 
was no significant difference in participants’ willingness to repeat the procedure when 
alfentanil was compared to midazolam (p = 0.65) or was compared to dexmedetomidine 
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(significance not documented), or when propofol infusion was compared to propofol 
boluses (p = 0.288), or when propofol with ketamine was compared with propofol and 
alfentanil (significance not documented), or nitrous oxide was compared to a placebo 
(significance not documented) (Atassi et al, 2005; Grendelmeier et al., 2014; Houghton et 
al., 2004; Hwang et al., 2005; Liao et al., 2012). When patient satisfaction was compared 
between Propofol/Ketamine and Propofol/Alfentanyl using a visual analogue score, 
Propofol/Ketamine was found to be more satisfactory (p < 0.05) (Hwang et al., 2005). 
Satisfaction scores were not significantly different when comparing Propofol/Remifentanil 
vs Propofol/Dexmedetomidine (significance not documented), Propofol/Alfentanil versus 
Propofol/placebo (significance not documented), or Fospropofol/ Fentanyl versus 
Fospropfol/Fentanyl (significance not documented) (Ryu et al., 2012; Silvestri et al., 2009; 
Yoon et al., 2011). 
2.6 Discussion 
The literature review found no qualitative studies that examined the patient experience 
during bronchoscopy with sedation and analgesia, therefore quantitative studies that 
measured aspects of the participant’s experience were investigated. The outcomes used 
during the studies were heterogenous making a meta-analysis inappropriate therefore a 
descriptive discussion of these outcomes is presented. The quality of these studies was also 
evaluated. 
In the included studies of the literature review, participants’ perceptions of their experience 
were measured using a variety of outcomes: distress, anxiety, pain, discomfort, cough, 
breathlessness, nausea, and choking. These outcomes were measured in a variety of ways 
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using visual analogues scales (0–10 or 0–100), Likert scales and dichotomous questions. 
There was no consistency in the comparators used, outcomes measured or the scales and 
tools employed to measure these outcomes, making it too difficult to synthesise the results 
for a meta-analysis. Regardless of the different ways in which the procedure was performed, 
participants acknowledged experiencing some discomfort, such as procedure-related 
distress, anxiety, pain, discomfort, cough, breathlessness, nausea, and choking. The 
underlying source of these outcomes was not explored in the quantitative studies.   
General patient satisfaction or willingness of the patient to return for a similar procedure 
was a common study outcome that was reported in the current literature. In two studies 
that measured both patient satisfaction and willingness to repeat the procedure, there was 
no consistency in the subjects’ rating of both outcomes, indicating that they measured 
different aspects of the experience (Hwang et al., 2005; Silvestri et al., 2009). In the study by 
Hwang et al. (2005), study subjects who were given propofol and ketamine had more 
amnesia and higher satisfaction scores than those given propofol and alfentanil. However, 
there was no difference between the groups in terms of the subjects’ willingness to repeat a 
procedure under the same conditions. In the study by Silvestri et al. (2009), the treatment 
group received high doses of fospropofol and the control group received lower doses of 
fospropofol. The treatment group had significantly higher ratings of amnesia and willingness 
to repeat the procedure, however there was no difference in comfort ratings or general 
satisfaction between these groups. In general, the literature review found that if, during 
bronchoscopy a treatment group was given sedation and a control group was given a 
placebo, then the satisfaction scores of the treatment group would be significantly higher 
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than those of the control group (Cases Viedma et al., 2010; Gonzalez et al., 2003; Rolo et al., 
2012).  
The included randomised controlled trials of adult patients undergoing flexible 
bronchoscopy since 2001 were identified as having some risk-of-bias problems. When they 
were appraised using the Cochrane risk-of-bias tool within the Covidence website 
(https://www.covidence.org/), the risk of bias was unclear in 30% of the judgements. Clark 
et al. (2009) had an almost perfect record of low bias but sequence generation was not 
described. Schlatter et al. (2011) published a study protocol and was judged as low bias in all 
other areas except selective outcome reporting, however it did not include data from some 
secondary outcome measures. This may be due to journal word limitations or non-
significant findings. Risk of bias was also high at times in relation to blinding of participants 
or personnel when work protocols and/or obstacles were present (Grendelmeier et al., 
2014; Liao et al., 2012; Lo et al., 2011). 
2.7 Review limitations 
A limitation of this systematic review was the quality of the randomised controlled trials 
that was identified as unclear in many studies. In general, the studies did not include clear 
descriptions of sequence generation, allocation concealment or blinding. Blinding was 
described as being too difficult in some studies due to study-site protocols and in many of 
the randomised controlled trials it was unclear if all outcomes were reported, as most 
studies did not provide a study protocol. The study by Schlatter (2011) did provide a study 
protocol, in which it was specified that data pertaining to patient side effects were to be 
collected 24 hours post-procedure, however in the study report there were no data 
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presented that related to patient side effects in that time frame. Another potential 
limitation identified as a source of bias in many of the studies was that patients were given 
more sedation when they were intolerant of the procedure. The inconsistency in outcomes 
should also be noted as factors that affected pooling of data from these randomised 
controlled trials. There was no consistency in outcomes selected to measure the patient 
experience, furthermore there was no consistency in the measures selected to assess 
outcomes or in the method of reporting the results.   
2.8 Conclusions 
In summary, the most frequent outcomes reported in the studies examining the patient 
experience in bronchoscopy were pain and cough. A commonly reported secondary 
outcome was patient willingness to repeat the procedure. Based on the current literature, it 
is concluded that providing sedation for patients during bronchoscopy results in reduced 
rates of distress, anxiety, pain, discomfort, cough, breathless, choking, and a greater 
willingness to repeat the procedure. Of note, the quality of the randomised controlled trials 
that are the basis of these conclusions is somewhat unclear, and a further source of bias was 
that in many of the studies patients were given more sedation when they were intolerant of 
the procedure. Given these findings, publishing study protocols may help to resolve many of 
the bias issues of the studies to date. Importantly, this review identified a significant gap in 
the literature; that outcomes were not selected based specifically upon the patient 
experience. No study could be located that qualitatively examined the patient experience of 
bronchoscopy, and there may be other unpleasant consequences of the procedure that to 
date have not been examined. A qualitative study that explores the patient experience in 
bronchoscopy may provide evidence for more consistency in outcome measures that could 
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be used to more effectively evaluate health care interventions, which may improve the 
patient experience of the bronchoscopy procedure.  
2.9 Chapter 2 summary 
This systematic review identified a gap in the literature concerning the patient experience of 
bronchoscopy with cautious sedation and analgesia: to date no qualitative study has been 
carried out on this topic. Thus, the second component of this thesis attempts to fill this gap 
by conducting an interview-based study to identify the experiences of patients with high-
risk respiratory disease during bronchoscopy. Further, the findings of the systematic review 
presented in Chapter 2 provide a guide for which to develop the conceptual framework and 
the questions that were used in the qualitative study. Chapter 3 details the conceptual 
framework, methodology and results of the qualitative study investigating the experiences 
of patients who have undergone bronchoscopy with cautious sedation and analgesia. 
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Chapter Three: Qualitative Study 
3.1 Overview 
Chapter Three presents the findings of a qualitative study that implemented an interview 
method to explore the experiences of patients with high-risk respiratory disease who have 
undergone bronchoscopy with cautious sedation and analgesia. To begin, the conceptual 
framework is described along with the study design and the methodology employed. 
3.2 Conceptual framework 
A conceptual framework can explain a researcher’s worldview of their research, enabling an 
identification of their rationale, assumptions and preconceptions (Lacey, 2010). This 
conceptual framework was developed after the research candidate evaluated their world 
view in relation to the clinical problem, their appraisal of literature dedicated to the clinical 
problem, and their exploration regarding the clinical problems fit with regard to potential 
research methods (Ravitch & Riggan, 2017). Concepts within the conceptual framework that 
relate to the research candidate’s world view include: patient suffering, patient advocacy, 
and patients’ best interests. Concepts that relate to the research candidate’s appraisal of 
the literature include:  literature that collects data relating to patient experience in 
bronchoscopy, guidelines relating to patient management during the procedure, and 
hospital policy regarding the procedure. After exploring the clinical problem fit with 
qualitative and quantitative research methodologies the research candidate selected 
phenomenological methodology as the most appropriate approach for this research.  
Phenomenological research methods explained by Van den Berg (1972) cited in van Manen 
(2014) encouraged the research candidate, who had a wealth of experience in the clinical 
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problem, to identify their assumptions, preconceptions and theories, then consciously 
disregard them in preference for the true story from the participants’ perspectives; their 
‘lived experience’. Thereby guarding against the effects of prejudice and assumptions born 
of theory, research and the candidate’s experience (van Manen, 2014), these concepts in 
the candidate’s conceptual framework overlap and interact with each other (see Figure 2).  
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Figure 2: Conceptual framework 
Suffering has been defined as the ‘undergoing of pain, distress or tribulation’ (Little et al., 
1988). A clinical problem arises when staff suspect that a patient is suffering as a result of a 
medical procedure. This could be the case when patients undergo bronchoscopy with 
cautious sedation because they may cough, choke, or try to remove the bronchoscope 
before the procedure is completed. The staff placate the patient with words whilst 
physically preventing them from removing the instrument. If they are able, the physician 
administers more sedation. In the time it takes for the additional sedation to take effect or if 
the physician deems it too risky to give more sedation, the question arises whether staff are 
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ignoring the patient’s needs, thereby potentially increasing their level of suffering 
(anecdotal evidence from the research candidate’s centre of practice). Berglund et al. (2012) 
found that patients experienced suffering in health care when their feelings were ignored, 
resulting in feelings of vulnerability and powerlessness. It may be that the patient reactions 
are unconscious and they will have no recollection of the procedure when sedation is used 
cautiously, as research has reported that sedation can cause amnesia (Cases Viedma et al., 
2010). 
Patient advocacy in nursing can be seen as pleading for better patient care (Harris, Nagy & 
Vardaxiz, 2010). Patient advocacy has been a driving force to complete this study because 
the research candidate wishes to clarify whether or not the patient is suffering and, if they 
are, are there any interventions that could be implemented to positively affect their 
experience of the procedure (for which the nurse can advocate). Patient advocacy is a 
responsibility that has been bestowed upon the nursing populace due to the immediate, 
sustained and intimate nature of nursing, which provides insights into the patient’s 
wellbeing (Gadow, as quoted in Gaylord & Grace, 1995). In the research candidate’s centre 
of practice, the nurse who provides airway support during a bronchoscopy stands at the 
patient’s head throughout the procedure, placing hands on their chin, holding their hand, 
talking to them and observing their behaviour, so that they may inform the physicians. 
Gaylord & Grace (1995) explain that, due to this special nurse-client relationship, failing to 
advocate for the patient can be synonymous with the nurse failing to conduct their duty. As 
such, it is a requirement of the Nursing and Midwifery Board of Australia (2008) that nurses 
protect their patients’ physical, psychological and emotional wellbeing. When the patients 
are given heavier sedation by an anaesthetist, the nurses have not observed patients 
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attempting to remove the bronchoscope before the procedure was completed 
(observations and anecdotal evidence from the research candidate’s centre of practice). 
Due to hospital and/or governmental financial constraints, anaesthetic support is not 
available for all bronchoscopy procedures and, in general, anaesthesia is used for 
interventional diagnostic or therapeutic procedures (these procedures are usually longer 
than general bronchoscopy procedures). Nursing advocacy is a driving force for the study 
but also contributed to the results. When the airway nurse talks to the patient, holds their 
hand and asks for more sedation during the procedure, they influence the patient 
experience. Exploring the patient experience through a qualitative study may ascertain ways 
to reduce possible suffering that quantitative studies are not able to achieve. Berglund et al. 
(2012) suggest that increasing knowledge regarding health care experiences would help to 
reduce unnecessary suffering. 
It is necessary for physicians to consider the patient’s best interests before embarking on 
any invasive procedures; the patient’s best interests can be established by weighing the 
benefits of the procedure against the risks of the procedure (Medical Board of Australia, 
2014). Studies have demonstrated that sedation during bronchoscopy can result in a more 
comfortable experience for the patient (Korteweg et al., 2004; Rolo et al., 2012). The 
literature associated with the sedatives administered during bronchoscopy (midazolam and 
propofol) has warned that these medications can decrease the patient’s respiratory function 
(AFT Pharmaceuticals, 2015; Apotex, 2014). Guidelines for patient management in 
bronchoscopy suggest that sedative drugs should be given cautiously when the patient has 
pre-existing respiratory disease (Du Rand et al., 2013). Bronchoscopy in itself can decrease 
respiratory function (Peacock, Benson-Mitchell & Godfrey, 1990). A study by Peacock, 
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Johnson and Blanton (1994) concluded that there was an increased risk of complications 
from bronchoscopy when the patient had COPD. These complications included infection, 
pneumothorax, oxygen desaturation, respiratory failure, and death. However, the patients 
in this study who had COPD were significantly older than the control group, and they had 
more specimens procured during the bronchoscopy (biopsy, needle aspiration, and 
brushings). In addition, they were given a significantly lower level of sedation than the 
control group. The retrospective nature of this study did not allow for measurement of 
patient satisfaction between the groups. Hattotuwa, Gamble, O’Shaughnessy, Jeffery & 
Barnes (2002) studied 57 patients who had COPD and underwent bronchoscopy with 
sedation. They reported that this group had a 2% incidence of adverse events that required 
hospitalisation, and therefore concluded that bronchoscopy could be performed with a low 
incidence of adverse events.  
When the physician contemplates the respiratory-compromised patient’s best interests, 
they are required weigh the benefits of the procedure (provide a diagnosis to create a 
treatment plan) against the risks of the procedure (infection, pneumothorax, oxygen 
desaturation, respiratory failure, death). To judge that the benefit of performing the 
procedure outweighs the risk to the patient, the physician must consider the benefits of 
sedation (improved patient comfort, amnesia) against its risks (desaturation, respiratory 
failure, death). A compromise is often reached whereby a decision is made to give sedation 
cautiously. It has been recommended by the British Thoracic Society (Du Rand, et al., 2013) 
that sedation is administered cautiously to patients who have COPD (Du Rand et al., 2013). 
A physician may justify continuing a procedure even if the patient appears to be suffering 
(attempts to remove the bronchoscope, coughing and choking) because some studies have 
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concluded that the sedative has an amnesic effect (Cases Viedma et al., 2010, Korttila, 
Saarnivaara, Tarkkanen, Himberg & Hytonen, 1978). Evidence in the literature regarding 
patient experience during bronchoscopy is limited to quantitative studies. These 
quantitative studies report that certain sedatives decrease the patient’s ratings of cough 
and pain during bronchoscopy (Atassi et al., 2005; Clark et al., 2009; Schlatter et al., 2011). 
Cases Videma et al. (2010) reported that the sedative midazolam is more effective in 
relieving discomfort and cough than a placebo. Clark et al. (2009) reported that propofol can 
improve patient tolerance and reduce cough when compared to midazolam during 
bronchoscopy. Using Propofol is expensive, as the drug guidelines recommend the presence 
of an anaesthetist due to its inherent short-acting respiratory risks (AFT Pharmaceuticals, 
2015). A recent survey of bronchoscopies in Australia and New Zealand reflected that there 
was a high use of anaesthetic support for sedation in bronchoscopy when it was performed 
in the private sector (Barnett, Jones & Simpson, 2016).  
Studies that have examined patient experience in bronchoscopy have influenced the patient 
experience positively due to the subsequent use of sedation in bronchoscopy (Salgado, 
Gomez, Navio & Anton-Pacheco, 2015; Barnett et al., 2016; Gaisl et al., 2016). However, 
there is also evidence to suggest that patients can remember discomfort, coughing and 
choking when undergoing bronchoscopy with sedation (Clark et al., 2009; Korteweg et al., 
2004; Gonzalez et al., 2003). The outcomes measured in quantitative studies are most 
commonly physical symptoms of cough and pain. The cause and effect of these physical 
experiences is largely unexplored qualitatively.  
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Some studies have looked at alternative interventions to improve the patient experience in 
bronchoscopy. Colt, Powers and Shanks (1999) reported that music did not alter the 
patient’s state of anxiety when undergoing bronchoscopy. Diette, Gregory, Lechtzin, 
Haponik, Devrotes & Rubin (2003) reported that distraction therapy with nature sights and 
sounds significantly reduces pain in patients undergoing bronchoscopy. A systematic review 
by Evans (2002) of 29 studies that investigated the effectiveness of music as a hospital 
intervention concluded that music did not reduce the anxiety of patients undergoing 
invasive procedures.  
Other studies have examined hospital procedures and healthcare workers’ techniques to 
identify factors that negatively affect the patient experience (Bernasconi, Chhajed, Müller & 
Borer, 2009; Contonli et al., 2013). The information collected is a rating of the patient 
experience in these areas. Obtaining information in this fashion does not necessarily 
facilitate the exploration of negative experiences. It is only by examining these negative 
experiences that the clinical problems associated with bronchoscopy may be ameliorated.  
3.3 Methodological approach 
To further understand the patient experience during bronchoscopy, a qualitative approach 
was used, employing phenomenology. Qualitative studies are focused on understanding the 
human experience as it is lived, through the collection and analysis of qualitative data that is 
subjective and descriptive (Polit & Beck, 2012). Conducting this type of research has given 
voice to the participants in this study. Phenomenology is a form of qualitative research 
where data are collected regarding a phenomenon, in this case, cautious use of sedation 
and analgesia during bronchoscopy.   
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Phenomenology attempts to describe the common meaning of a particular experience 
(phenomenon) for several individuals (Creswell, 2013). It examines the pure, basic and raw 
sensations, emotions and thoughts experienced by individuals who have experienced the 
phenomenon, the purpose of which is to present a piece of work that faithfully represents 
the participants’ experiences and what it means to them (Denscombe, 2010). In health care, 
phenomenology can help the researcher to understand the thinking of patients during a 
healthcare intervention (Denscombe, 2010).  
There are two main types of phenomenology: descriptive and interpretative. 
Phenemonology was founded in Europe by Edmund Husserl in 1908 when he pushed to 
transform philosophy into a rigorous science (Husserl, 2014). Husserl’s approach was purely 
descriptive; he used phenomenology to philosophically describe the essence of a pure 
experience (van Manen, 2014). The essence of pure experience refers to the conscious 
experience of the participant during the phenomenon. In practice, this method includes the 
researcher bracketing their own preconceived beliefs and opinions about the phenomenon, 
to improve their vision of the ‘essence of pure experience’ (Husserl, 2014). Data are 
collected and analysed, and a description of the phenomenon’s pure essence is presented 
(Grbich, 2013). 
A student of Husserl, Heidegger, developed an interpretive approach called hermeneutics 
(Polit & Beck 2012), which not only described the patient experience of the phenomenon 
but interpretation and understanding of the human experience (Polit & Beck 2012). Van 
Manen’s 1990–2014 writings further developed the hermeneutic method. His approach to 
phenomenology (1990; 1997; 2014) was selected for this research study. He describes 
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phenomenology as a ‘meaning-giving’ method of research (van Manen, 2014). The aim of 
this method of research is to enable an understanding of how the experience affects the 
participant. His methods have been chosen for this study as the generalised meaning of 
participants’ experience may influence healthcare plans, education tools and workers’ 
empathy, and uncover previously overlooked issues (King & Thomas, 2013; Schneider, 
Whitehead, Elliott, Lobiondo-Wood & Haber, 2007). An understanding of how bronchoscopy 
affects the patient will enable staff to alter interventions during the procedure to improve 
the patient experience, or it may reassure staff that patients are not adversely affected by 
the procedure.  
Van Manen’s analysis involves teasing out themes from the data collected. In order to 
understand the participants’ experiences of their world during the phenomenon, van 
Manen (1990; 1997; 2014) suggests reflecting on how the study’s themes relate to universal 
themes of life: space, body, time and relationality. In this study, these universal themes 
refer to the day surgery and procedural space, sensations that the participant feels, 
participants’ concept of time, and their interactions with healthcare workers. Presentation 
of these themes provides a generalised meaning of the participants’ experience.  
There are some advantages of phenomenology that coincide with this study. It is suitable for 
small-scale research where the budget is low, as it mainly relies on in-depth interviews 
rather than requiring sophisticated equipment: the main resource is the researcher 
themself. Phenomenological descriptions of the experiences can create interesting stories 
that could attract a wide range of readers. The stories can offer authentic accounts of the 
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complex phenomenon. It is also considered a humanistic type of research, as the researcher 
is making an effort to base their enquiry on human experiences (Denscombe, 2010).  
Researchers who do not practise phenomenology often criticise the method by suggesting 
that it lacks scientific rigour: it is mainly descriptive, leads to problems with generalisation, 
and researchers have difficulty suspending presumptions, therefore results can be coloured 
by the researcher’s beliefs (Denscombe, 2010). Van Manen’s approach systematically 
attempts to uncover and describe the meaning of a lived experience (van Manen, 1990). His 
formalised methods of data collection, analysis and writing give structure to a research 
design, promoting credibility and dependability. His approach is not just a description of the 
participants’ experience of the phenomenon but an interpretation of how it affects them.  
Van Manen has proposed a researcher mind-set to reduce presumptions and beliefs from 
colouring the data, analysis and writing (van Manen 1990; 1997; 2014). He claims that 
researchers often know too much about a phenomenon from exposure to literature and life 
experience (van Manen, 1984), and it is therefore too difficult to bracket their own ideas. He 
suggests that it is better to be explicit about preconceived ideas, biases and theories as they 
are shallow in comparison with the real data that are collected (van Manen, 1984). He also 
suggests that the researcher identifies and maintains an awareness of these preconceptions 
to limit their effect on the research reflections (van Manen, 1984; 1990). Dowling (2007) 
also suggests that bracketing is not appropriate in the interview phase as it restricts 
development of a rapport between the researcher and participant. The research candidate, 
for this study, made two main assumptions: an axiological assumption that the combative 
patient finds the procedure traumatic, and an ontological assumption that each 
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participant’s experience is different depending on their personality, background and 
personal experience (Creswell, 2013). 
3.4 Research design 
3.4.1 Clinical problem 
A clinical problem was identified during some bronchoscopies where the patients were 
given sedation and analgesia cautiously, and the nurse assisting with patient airway 
perceived that the patient was in distress. The common perceived symptom of distress was 
when the patient attempted to remove the bronchoscope before the procedure was 
completed. 
3.4.2 Cautious sedation and analgesia 
Even though generally used in practice, there is no medical definition of cautious sedation 
and analgesia, therefore routine practices of physicians were observed, clinical expertise 
was sought, and data were collected and used to develop the following definition, for the 
purposes of this study:  
Administration of sedation and analgesia in small doses over an extended 
period, whereby the patient can be aroused by verbal command or touch, 
has spontaneous ventilation and cardiovascular function also remains stable. 
In practice,  
The clinician administers midazolam in 1–2mg doses and fentanyl in 25mcg 
doses, waits one to two minutes after each individual dose, and observes 
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the patient’s response (cautious sedation and analgesia). When adequate 
sedation is achieved, the procedure is commenced. If the patient wakes 
during the procedure then additional doses of midazolam or fentanyl may 
be administered up to a maximum of 5mg and 100mcg, respectively.   
(Definition was created by Catherine Saxon with the assistance of Paul Fulbrook, Steven 
Leong, Rayleen Bowman and Kwun Fong, 2013.) 
3.4.3 Research question 
To investigate the clinical problem identified, a greater understanding of the patient 
experience was required. The aim was to provide examples of patients’ experiences to 
influence embedded views of treating physicians (such as, patients do not remember the 
procedure due to the amnesic effect of sedative drugs), which in turn may influence 
practices. 
The following research question was developed:  
What are the experiences of patients undergoing flexible bronchoscopy 
with sedation and analgesia, particularly those with high-risk respiratory 
disease that require ‘cautious’ sedation and analgesia? 
3.4.4 Research aim 
The aim of the project was to understand the lived experience of patients with high-risk 
respiratory disease who have undergone bronchoscopy with cautious administration of 
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sedation and analgesia. The findings of this study will be used to inform bronchoscopy 
practice. 
3.4.5 Setting 
To decrease the time burden on participants, recruitment and interviews were conducted at 
The Prince Charles Hospital in Chermside, Queensland, in the departments where the 
patients would ordinarily receive medical care or treatment (outpatients department and 
post anaesthetic care unit). To maintain patient privacy, a private room was allocated for 
communication between the research candidate and the participants. All areas were fitted 
with emergency equipment and offered nearby access to medical staff.  
3.4.6 Data collection 
Data collection was conducted by the research candidate (a senior nurse experienced in 
bronchoscopy). No participants in the study received direct nursing care from the research 
candidate. Data were collected with face-to-face interviews. Phenomenological research 
relies on in-depth interviews with relatively few participants, sometimes with multiple 
interviews for each participant (Polit & Beck, 2012). Along with interview transcripts and 
interview notes, the following participants’ characteristics were collected: age, gender, 
ethnicity, weight, indications for bronchoscopy, procedure type, medication administered, 
length of procedure, and length of interviews. 
3.4.7 Evaluation of methods 
To establish and maintain the credibility and authenticity of the study, an audit trail was 
developed to enable review of interview transcripts, data analysis and data syntheses by 
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Professor Paul Fulbrook (Polit & Beck, 2012). The repetition of themes between patients and 
during subsequent unstructured interviews was used to confirm data accuracy (Polit & Beck, 
2012). 
3.4.8 Ethical issues  
Before the study started, ethic approvals were obtained from the HREC authorisation from 
the Research Governance Office (HREC/14/QPCH/49), site specific ethics approval 
(SSA/14/QPCH/90), and Australian Catholic University (2014160Q). The ethical issues 
considered were consent, confidentiality, risks versus benefits (National Health and Medical 
Research Council, 2007). 
When approaching potential participants, the research candidate was empathetic, polite 
and enthusiastic when giving verbal and written study information (Polit & Beck, 2012). 
They were told that they were invited to participate in the study because they were going to 
have a bronchoscopy and they had a history of respiratory disease. They were informed that 
the aim of the study was to understand the experience of patients with chronic respiratory 
disease who underwent bronchoscopy and that this information could help improve the 
care and treatment of future patients, and that the potential commitment of the participant 
would be participation in two, one-hour, digitally recorded interviews. The first interview 
would take place two hours after the procedure and the other at their follow-up 
appointment or over the phone if they would not be returning to the hospital. The 
interviews were described as a conversation with someone, where they are doing most of 
the talking, so that they can talk about their personal experience. An example of the 
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questions asked is ‘today you had a bronchoscopy, how did that make you feel or what was 
it like for you?’ All this information was given in layman’s terms. 
The study information provided included how participants were selected for the study, that 
participation was voluntary, that they could withdraw at any time, and that their treatment 
would not be compromised if they refused to participate or withdrew from the study. Also 
included in the study information were the goals of the study, the type of data collected, the 
time commitment, examples of unstructured interview questions, a pledge of confidentiality 
and anonymity, the main risks and benefits to the participants, and the research candidate’s 
contact information. To prevent coercion, potential participants were not asked to consent 
when they were in theatre, nor were they offered inappropriate gifts or promises of better 
treatment if they participated (Rebar, Gersch, Macnee & McCabe, 2011).  
Potential participants were told that all their information would be kept confidential and 
private, and that their name and contact details would be kept separate from their study 
data. To maintain confidentiality, interviews would be conducted in private rooms. 
Participants would be given a pseudonym before the digitally recorded interview to 
minimise the risk of identification. 
All information obtained during the interview was treated according to ethical guidelines 
(National Health and Medical Research Council, 2007). Computer files were stored in 
password-protected files. Consent forms, digital interview recordings and transcripts were 
securely stored at all times to prevent loss, damage or misuse. When not in use, the data 
were stored in a locked filing cabinet in the Nursing Research and Practice Development 
Centre, on level 5 of the Clinical Sciences Building at The Prince Charles Hospital. All data will 
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be destroyed five years post study publication; electronic files will be deleted and paper will 
be shredded (Australian Catholic University, 2013; Greene, 2009; National Health and 
Medical Research Council, 2007). 
3.4.9 Risks versus benefits 
Benefits of the study to the participant included debriefing (emotional processing, 
education, reassurance and social support (North & Yutzy, 2010); stimulation by 
participation, and pride for contribution to health care (Polit & Beck, 2012). At the end of 
the two interviews, each participant was given a $25 gift certificate to compensate for costs 
associated with participation in the project such as loss of time, transport, and parking. 
Potential risks included psychological distress, fatigue, boredom and loss of time in the 
interview process (Polit & Beck, 2012). These risks were minimised by the professional 
psychological and medical support provided during the interview process and no such 
problems were identified during the interview process. 
To reduce risks associated with psychological or physical distress in the patient with 
respiratory disease, the following plan for psychological and physical distress was 
developed. In order to provide minimal psychological distress, interviews were 
unstructured, allowing participants to talk as much or as little about the experience as they 
desired. If distress occurred, the interview was to be halted and the participant was to be 
given the option to continue when they were calm, or given the opportunity to reschedule 
the interview for another convenient time, or they could withdraw from the study. If 
required, the participants would have been given a referral to the onsite psychologist or 
accompanied to the mental health acute care department. 
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To reduce the risk of physical distress, candidates who had a history of shortness of breath 
or chest pain associated with emotional distress were to be withdrawn from the study. Safe 
management of physical distress involved access to emergency equipment in all interview 
rooms, including an emergency buzzer system to notify emergency medical staff. The 
interviewer also had documented competency in basic life support and clinical experience in 
observation and management of patients with physical distress. At all times, participants 
had access to medical staff to facilitate administration of oxygen if required and to provide 
other emergency health care. If required, the participant could also have obtained a referral 
to the mental health department to learn techniques to limit respiratory symptoms when 
distressed. This did not occur during any of the participants’ interviews. 
3.4.10 Recruitment methods 
Purposive sampling was used to recruit up to 15 participants (allowing for participant 
withdrawal or exclusion due to participants’ clinical condition). The inclusion criteria were: 
• patients who were scheduled for a bronchoscopy with cautious sedation and 
analgesia 
• patients who had COPD and/or respiratory failure.  
Recruitment occurred after the patient’s outpatient appointment when the physician had 
decided it was medically advisable to perform a bronchoscopy.  
3.5 Data collection 
Merriam (2009) determined that interviews are necessary when the participant’s 
interpretation of a phenomenon is required. Some advantages of data collection via 
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interviews include depth of information provided, insights, minimal equipment 
requirements, participants’ priorities can be identified, flexibility, high response rate, high 
validity, and may be therapeutic to participants (Denscombe, 2010). Interviews can produce 
depth and detail regarding a subject with appropriate probing and length, leading to new 
insights. Interviews also enable the consideration of participants’ tone, body language, 
priorities, opinions and ideas. Interviews can be flexible, as questions can be changed to 
collect the appropriate data from different types of participants with different personalities 
and stories. Response rates are usually high, as interviews can be rearranged to suit the 
participant. The interview enabled direct contact with the participant, and data were 
checked for accuracy and relevance at the time of the interview, therefore promoting 
validity. Interviews may also have been therapeutic to the participant, as they were able to 
debrief about an experience to someone whose purpose was to listen, take note of their 
ideas and not be critical (Denscombe, 2010). 
Some disadvantages of interviews include the amount of time taken, no standardisation of 
data collected, participants may not have told the truth, and digitally recording interviews 
may have inhibited some participants (Denscombe, 2010). The time burden on the 
participant was increased with data collection via an interview. Interviewing, transcribing 
interviews and analysing data were all time consuming, but that was a sacrifice that the 
research candidate was willing to take, in order to collect this type of data. The data that 
were collected were a reflection of the unique experience of the individual participant. 
Some researchers may argue that this adversely affects reliability and generalisability. Social 
desirability may also have influenced the responses of the participants, in that the 
participant may have told the researcher what they thought the researcher wanted to hear. 
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To help manage this, the research candidate wore clothes that were of equivalent status to 
the participant, rather than a uniform, to ensure that they did not look like a health 
professional. Van Manen (1990) also advises that the researcher be personable in order to 
win the trust of the interviewee. He further suggests that the researcher dress neatly in 
casual attire so they look approachable and that they should be friendly before requesting 
information on the phenomenon under examination (van Manen, 1990).  
Participants were involved in two in-depth, unstructured, digitally recorded interviews. The 
first interview was conducted around one hour post-procedure, prior to discharge, and the 
second interview was held 1–10 days later, at the participant’s convenience, in the 
outpatient department (while waiting for results) or by telephone if the participant was not 
required to return to the outpatient department. The second interview allowed for further 
fact checking, and was also unstructured. Each of the participants’ two interviews was 
compared for consistency regarding their experience. 
The telephone interview allowed collection of data from participants at distant geographical 
locations (Denscombe, 2010). The telephone interviews had some disadvantages compared 
to the face-to-face interviews in that there was a reduction in non-verbal cues. Non-verbal 
cues can assist with determining the meaning of the participants’ experience and the truth 
of the participants’ recollections. Other difficulties that were considered were the difficulty 
in determining if contact was with the correct person, that participants may be less open 
and/or uncooperative during a phone conversation, and that phone calls were unlikely to 
exceed 20–30 minutes. One participant was uncooperative regarding the scheduling of the 
second interview and another was very distressed and did not want to participate in a 
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second interview, having been given a diagnosis of lung cancer. In both cases, the first 
interview was used for study data and no second interview was conducted. Interview 
recordings were transcribed verbatim and combined with the research candidate’s field 
notes (observations related to participants’ verbal tone and body language during the 
interview).  
Van Manen’s (2014) objective in phenomenological interviewing is to obtain an account of a 
participant’s lived experience in narrative form, not a discussion about the experience. He 
concedes that this is very difficult and provides several pointers regarding settings, 
researcher approach and time constraints. He suggests that formal settings are not 
conducive to thinking about life stories. In order to promote patient privacy, interviews 
were held in a private room. Due to patient safety requirements, the interviews were 
conducted in rooms of the hospital but the research candidate only included essential 
medical equipment in the room, which was discreetly positioned. The participants were 
offered a hot or cold drink and snack of their choice, not hospital issue or in hospital 
crockery. When the experience of the phenomenon was broached, the research candidate 
was enthusiastic and open about the subject. In order to promote a full account of the 
participant’s experience, the interview was arranged for when it did not need to be rushed 
(van Manen, 2014), that is, one hour prior to discharge.  
The research candidate turned on the recorder at the beginning of the interview and then 
had a friendly conversation before data collection was commenced to allow inhibitions to 
wear off. The research candidate was friendly and courteous at all times, and conducted the 
interview as a conversation so the participant did not have to give more information than 
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they wished. Instead of asking questions to start data collection, van Manen (1990) suggests 
asking the participant to think of the phenomenon then explore the experience to the 
fullest. Prompts to facilitate the interview included ‘tell me what that was like for you’, or 
‘how did that make you feel?’. Other suggestions included silence to allow the respondents 
to gather their thoughts, repeating the respondent’s last sentence if they got lost or if the 
respondent started to generalise the experience. The research candidate asked questions 
such as ‘What was it like for you?’ (van Manen, 1990). 
3.6 Data analysis 
Van Manen (1990; 1997; 2014) suggests three methods to uncover thematic aspects of the 
experience: 
• Wholistic approach: the researcher reviews the data collected for each interview, 
selects any significant phrases within the text that capture the whole text’s central 
meaning, and formulates a phrase to express the central meaning.  
• Selective reading: the researcher reads the text several times, and highlights 
statements or phrases that are important or revealing about the phenomenon. 
• Line by line approach: the researcher reads every sentence or paragraph and 
interprets what each sentence reveals about the phenomenon. 
When using these three approaches to study the text, several themes emerged (see 
example in Table 7). The themes were consolidated and refined as they arose in different 
participants’ interviews. Van Manen (1990) suggests reflecting on the study themes in 
relation to the participants’ world. For ease of analysis, he suggests breaking up the 
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participants’ world into four existential themes. These four themes are considered 
interactive and can help express the participants’ world (van Manen, 1990):  
• Spaciality (Space): participants’ perceptions of the space in which the phenomenon 
occurs. 
• Corporeality (Body): how the participants’ physical, emotional, psychological body 
and presence is affected by the phenomenon (bronchoscopy). 
• Temporality (Time): the participants’ subjective perception of time before, during 
and after the phenomenon. 
• Relationality (Others): interactions between the participant and other people during 
the phenomenon. 
The final analysis involved writing and re-writing about the themes (van Manen, 1990). Data 
were presented thematically; each theme was described and represents the participant’s 
experiences of the phenomenon (van Manen, 1990). 
Note: The study protocol and ethical paperwork were written and approved prior to the 
publication of van Manen’s 2014 text in which he included an additional existential theme: 
Materiality (Lived things). Due to ethical restrictions, this existential theme was not 
considered in the current study.  
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Table 7: Example of analysis process 
Method Description Example 
Wholistic 
approach 
Written phrase that 
expresses the 
central meaning 
John found the throat spray and introduction of the 
instrument into his throat made him choke and he tried 
to cough it out. John could hear them discussing the 
procedure and feel the instrument wriggle inside him. 
John was angry but accepting of his circumstances. 
Selective 
approach 
Selection of phrase 
that is revealing 
about the 
phenomenon 
Oh tried coughing it up all the way down, and every now 
and then they would move it or wriggle it and you can 
feel that, and it made you want to cough. Yeah. There 
was no real pain or anything. Just really made it cough. 
They yeah, said a bit more, and a bit more, and another 
one of these, and another one of them, and away they 
kept on going until I got done. 2a4.2 (2nd participant, 1st 
interview, page 4, line 2 of interview transcript) 
Line by line 
approach 
Line by line 
Interpretation 
I don’t want to choke 2a5.20 (2ND participant, 1st 
interview, page 5, line 20 of interview transcript) 
John was upset that the procedure made him choke.  
Reflection of the 
theme in 
relationship to 
the world we live 
in 
Space, body, time, 
relationality 
Space: John was aware during the procedure.  
Body: The procedure made John cough and choke, he did 
not feel any pain and he could feel the scope moving 
inside him. He was angry that the procedure made him 
choke. 
Relationality: John could hear the doctors talking, he 
knew they were doing their job. He said all the staff were 
good down there. He was angry that he did not go to 
sleep. He did not blame the doctors for his choking and 
coughing.   
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3.7 Findings 
3.7.1 Participants 
To provide rich examples of the phenomenon, 13 participants were interviewed. After the 
interviews were transcribed and analysed, it was judged that the data were sufficient and of 
adequate quality (Malterud, Siersma & Guassora, 2016). All participants were diagnosed 
with the high-risk respiratory disease, COPD. All bar one participant had been told that they 
may have lung cancer and that the procedure would help make a diagnosis. Due to the 
organisation’s cohort, all participants were white Australians. They were aged between 30 
and 70 years and were predominantly male (see Table 8). In Australia, the rate of COPD 
increases with age and is higher in males (Australian Institute of Health and Welfare, 2017). 
Three participants declined to participate in the study. Twelve participants were excluded 
from participating for the following reasons:  their follow-up outpatient appointment was 
too late for conducting the second interview, they were given amounts of sedation greater 
than the study’s definition of cautious sedation, they had a sore throat after the procedure, 
or their procedure was abandoned or cancelled (see Table 9). 
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Table 8: Participant and procedure details 
Participant 
pseudonym 
Age 
(years) 
Gender  Weight 
(kg) 
Lignocaine 
(mg) 
Midazolam 
(mg) 
Fentanyl 
(mcg) 
Indications for procedure Procedure Length of 
procedure 
(min) 
Bob 59 M 
 
76 220 4 75 Haemoptysis + RML mass Diagnostic + BAL 31 
John 65 M 83 260 7 0 Shortness of breath, 
changes on x-ray 
Diagnostic +EBUS G/S 55 
June 79 F 60 200 4 75 X-ray changes Diagnostic +EBUS G/S 46 
George 80 M 82 200 5 0 Haemoptysis + Right 
Pleural  effusion 
Diagnostic + Wash 9 
Ian 79 M 77 220 3.5 100 Haemoptysis Diagnostic + Wash 23 
Nathan 81 M 74 220 5 100 RLL Mass Diagnostic +EBUS G/S 25 
Kelly 78 F 72 260 4 75 RML Mass Bronch +TBLBx 23 
Penny 70 F 65 220 5 100 Haemoptysis + history of 
lung cancer 
Diagnostic + Wash 19 
Mark 55 M 35 220 5 100 RL mass Diagnostic +EBUS G/S 28 
Rachel 35 F 34 140 3 100 Persistent cough 
bronchiectasis 
Diagnostic + Wash 9 
Sam 69 M 124 220 2.5 50 Haemoptysis + history of 
small  cell  lung cancer 
Diagnostic + Wash 15 
Alec 48 M 98 260 8 100 Lung mass Diagnostic + Wash + Endo 
bronchial  biopsy and 
brush 
32 
Cameron 56 M 74 140 5 100 Haemoptysis Diagnostic + Wash 22 
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Table 9: Excluded participants  
Reason N (%) 
Follow-up appointment too late for interview 1 (6) 
Cautious sedation not used 8 (53) 
Procedure failed  1 (6) 
Procedure cancelled 1 (6) 
Participant withdrew due to sore throat post-procedure 1 (6) 
Total 12  
 
3.7.2 Themes 
Six themes emerged from the data analysis: ‘Waiting there’; ‘The worst part’; ‘Being aware’; 
‘Feelings of comfort and safety’; ‘After effects’; and ‘Feelings of acceptance or 
dissatisfaction’. 
‘Waiting there’ included the participants’ experiences of frustration and where they dwelt 
on their fears. The ‘worst part’ for participants in this study was the choking and coughing 
they experienced. ‘Being aware’ during the procedure meant that they recalled episodes of 
choking and coughing and were hurt by physicians’ conversations that they overheard 
during the procedure. Participants also reported on the ‘Feelings of comfort and safety’ 
during the procedure. As denoted by the theme ‘After effects’, there were notable physical 
and psychological effects of the procedure. ‘Feelings of acceptance or dissatisfaction’ 
reflects that participants often accepted their negative experiences due to their perception 
that the procedure was a necessary evil but some participants remained hurt and angry due 
to their experience; they felt that they should have been treated differently.   
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3.7.2.1 Waiting there 
This theme is a result of exploring participants’ experiences before and after the procedure. 
Feelings of frustration were common during the waiting time before the bronchoscopy. 
Participants discussed waiting for long periods, going without food for too long, and having 
to complete a large amount of paperwork for admission. These circumstances, along with 
fear and anxiety regarding their procedure and potential diagnosis, were compounded while 
they were ‘waiting there’. Ian and George were particularly frustrated by the waiting time 
and length of fasting pre-procedure: 
I arrived there at ten past eight, and I never got into the theatre until quarter 
past one, and I’d been on a fasting from the afternoon before. I went—oh 
well you can say I went twenty hours without food … That is something that 
will have to be improved on. What happened to country people getting 
priority? (Ian) 
I was waiting there longer than what it took. I was supposed to have it—I 
was first off the rank they told me at eight am. The got me—the car that 
comes from Bribie—they go all over Bribie more or less, but they only picked 
up about two, four, six or seven passengers and I got in about seven forty. I 
thought, oh well I’ll get in straight away. But there were other people here 
before me and they got in before me and they got it. (George) 
From these discussions, it was clear that some participants waited and fasted a long time 
before the procedure. Having hunger pains did not make the experience enjoyable for them. 
Participants did not discuss their occupation during the time they waited before the 
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procedure, other than their frustrations and fears. While waiting post-procedure, Kelly felt 
neglected. She did not know who her nurse was and when the doctor was coming to give 
her the results. 
I have to say it degenerated ... I didn’t get to leave until four o’clock ... I said 
to somebody passing by, ‘Excuse me but how long do you think I’m going to 
have to be here now?’ This lovely young woman said, ‘Who’s your nurse?’ I 
said, ‘I don’t know.’ … nobody seemed to give an axe whether I was there or 
I wasn’t, or anything else … (Kelly) 
Kelly’s feelings were compounded by the space in which she recovered. It was busy with 
numerous patients; she was told to go to sleep by staff despite these circumstances.  
Why don't you have a snooze? Yeah, well how the hell can you have a 
snooze when there’s about 20 people roaring around? … Now, I don’t mind 
at all not sleeping, because I’m not a sleeper. But the idea of suggesting to 
someone that, oh why don’t you have a snooze while you’re waiting to get 
your tea and sandwich, I mean, hello. Have a snooze? Give me another shot 
and then maybe I’ll have a snooze. (Kelly) 
Kelly’s interactions with the staff during recovery led to feelings of frustration and hurt; she 
felt the staff did not care.  
Some participants were not concerned about long waiting times. Alec was aware of his 
environment while he waited. He was aware that the staff were busy and had commitments 
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before his procedure. He accepted that, even though it was not optimal, as described below, 
he had to wait. 
I was in the recovery room before the procedure on the long list, but I 
suppose you’ve got to wait in line for your turn, but other than that, I was 
really impressed. (Alec) 
John and Kelly were particularly frustrated by the paperwork required pre-procedure; they 
felt it was excessive: 
The nurse took me in and done all the paperwork. Seemed liked 10 mile of it 
... just too much paperwork. Even the nurse is struggling with it, I reckon. 
(John) 
… as an old public servant who used to be pretty good at paperwork, it 
seems to me that there’s a huge amount of repetition and strange things, 
like sending you home with an envelope full of stuff for you to read and fill in 
prior to your procedure, which makes a great deal of sense. But then when 
you get here, they’ve got yet another form which asks for very similar 
information but in more detail and different things like specialist. (Kelly) 
Participants’ perceptions of the hospital’s admission procedure were not always positive. 
They often found the environment and interactions with the staff frustrating in relation to 
paperwork, waiting and fasting time. Further, their fears contributed to the negative 
experience of waiting there. A common fear among participants was that the procedure 
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would hurt. They were scared that the procedure would be uncomfortable and make them 
cough. This is illustrated in the following quotes: 
Pretty nervous beforehand actually ... oh, just the fact they were going to 
stick cameras down my throat ... I was worried about—yeah, well, whether 
I was going to cough, you know was it going to be sore afterwards and 
things like that you know? (Alec) 
I thought it was going to be actually very cruel … I expected it to be hurtful 
… I was dreading it so much. (June) 
Two participants were not scared; the basis for this lack of fear focused on their 
experience of similar procedures and religious faith. See quotes from Kelly and 
Ian below: 
I’m not a nervous … I’m a very stoic person … I’ve had a lot of endoscopies 
and it’s very similar. (Kelly) 
I wasn’t even—not nervy about it. I don’t know, it’s—I’ve just got faith in 
this. I believe there is arrangements. (Ian) 
Fear or anxiety related to the participant’s potential diagnosis was a common experience. 
Most participants were aware that they may have lung cancer and the bronchoscopy was a 
tool to confirm or deny this diagnosis. Participants’ experiences of fear and anxiety, relating 
to their procedural results, are illustrated in the following quotes: 
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A bit nervous about seeing any of them … I just don't like the results 
sometimes. (John) 
I'm just hoping it’s not very big. (June) 
I’m still ‘trepidatious’ because I don’t know what the result is going to be … 
of course, today is the day I really find out. (Kelly) 
When I’m coughing up blood like that, I thought I’d definitely have to—but 
they’re saying the CAT scan and the X-rays have come up good. But I 
suppose there’s no guarantee still. Now I’ll just wait and see. I got here as 
early as I can. If you put things off—keep putting things off, you’re going to 
die. Things only get worse. That’s what happened to my father. (Cameron) 
The psychological strain was evident during participants’ conversations. For example, Bob 
said: 
Woke up in the middle of the night and you know you just sort of hash a 
few things … a big infection or it could be a cancer ... it was just churning 
away inside … So some sort of pre-med I suppose, something to calm you 
down a bit.  
Participants were worried about how much time they would have to live, if they had lung 
cancer. As one participant stated, 
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I won’t find out about it until Thursday but it has been a long, I found out 
basically last Tuesday so it has been a long week. And to go from waking up 
in the morning to possibly having it. (Mark) 
I'm hoping it could be a year, it could be 10 years or something, 20 years. 
(Bob) 
In summary, this theme describes the participant experience while ‘waiting there’, i.e. 
before their procedure. No participants described this as a pleasurable experience, and the 
waiting time was perceived as excessive. The physical and psychological effects of waiting 
included feelings of hunger, frustration, neglect and fear. Participants feared that the 
procedure would hurt and the results would determine how much longer they had to live. 
Interactions with staff on admission included excessive amounts of paperwork, for the 
participants and the nurses. Over an extended period of time, the staff in recovery were 
unable maintain positive interactions with a participant, leaving them feeling neglected, 
which was exacerbated by their perception that the recovery room was noisy and not 
conducive to sleep. Although the waiting period was largely considered to be a largely 
negative experience, participants did not perceive this as the worst part of their experience. 
3.7.2.2 The worst part 
When participants were not aware during the procedure, they commonly described the 
throat spray as the worst part of their experience. It was considered distasteful, and 
resulted in feelings of choking and difficulty in swallowing. This is illustrated in the quotes 
below: 
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I always comment about how horrible it tastes … I have to say that that 
was uncomfortable for a little bit, because you could feel that there was 
mucus there but you felt you couldn’t swallow, although he assured me 
that you can swallow you just don’t think you’re swallowing. (Kelly) 
The worst part was spraying the stuff in my mouth … just yucky, you know 
… Whether he didn’t wait long enough or what, and I gagged and it was 
dreadful, absolutely dreadful. I was so glad when he finished. I thought that 
… I’m going to gag. (June) 
The spray that they put down your throat … I don’t know what it is 
supposed to do but yeah. It built up, built up and there was a bit of a gurgle 
up. Sort of you can’t breathe because it’s stuck in your throat. (Ian) 
Coughing and/or choking during the procedure were the worst part of the experience for 
some participants. They remembered the coughing and choking because they were aware 
during the procedure. This was upsetting for them, however they did not want to make the 
procedure more difficult for the physician because they felt that the physician was trying to 
help them. Participants were also worried that the physician’s ability to obtain a diagnosis 
for their condition would be thwarted if they continued coughing, but they could not stop 
the coughing so they became upset.  
Had this thing stuck down me throat … tried coughing it up all the way 
down, and every now and then they would move it or wriggle it and you 
can feel that, and it made you want to cough ... There was no real pain or 
anything. Just really made it cough … Choking was the worst. I felt I didn’t 
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want to choke, because it would probably make it harder for them, so I was 
struggling not to cough or anything. But yeah I suppose that was the worst 
part … maybe they've got enough I don't know. (John) 
I coughed nearly all the time that he was doing it ... They kept spraying 
inside the mouth to ... well they were trying to stop the coughing because I 
couldn’t help coughing … I knew I was coughing a lot … I couldn’t help 
coughing because you’ve got this thing in your throat … When I didn’t go to 
sleep, well I felt that I would have been better if I went to sleep … You see, 
last time I had the—whatever you call it, right down into my lung they put 
me out; right out and I had a good sleep. But this time they didn’t … 
(George) 
The worst part for participants was the physical experience of coughing and choking. This 
resulted in feelings of distress. This, in part, was due to participants’ desire to not make the 
procedure difficult for the staff. Participants expressed a high regard for the staff and a 
strong desire to obtain a diagnosis of their condition.   
3.7.2.3 Being aware 
Participants’ experiences of being aware during the procedure included coughing and 
choking, difficulty breathing, fear that they were disrupting the procedure, and hearing 
information at an inappropriate time. When participants were aware during the procedure, 
they were aware of what the staff were talking about. This was particularly concerning for 
Bob, because he thought he needed a biopsy to obtain a diagnosis regarding his possible 
lung cancer. When he overheard that the doctors could not take a biopsy he was angry. He 
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thought this would prolong the process for his diagnosis. He wanted to know how much 
longer he had to live. 
I can remember like them saying … can’t go there … no, can’t see it there … 
I could almost tell where they were poking the ’scope from the way they 
were talking … but I couldn’t feel anything … now I know they haven’t done 
a biopsy ... I can’t see how they’re going to tell anything. (Bob) 
Being aware during the procedure caused physical difficulties in breathing and coughing. 
Participants found the mouth guard inserted prior to the procedure to be uncomfortable. 
They were often perturbed by having their eyes partially covered with a cloth. Some could 
remember seeing the thin black instrument (bronchoscope) when it was inserted into their 
mouth, and some participants felt that the physicians should have put them to sleep. In 
addition, when participants were awake during the procedure, they said that this caused 
further anxiety because they were given an additional opportunity to worry about their 
circumstances and success of the procedure. 
They covered my eyes up and they put this thing in your mouth (mouth 
guard) and it’s a bit hard to breathe …. I went through the whole thing. I 
couldn’t feel him doing—not down but it didn’t hurt. I cough nearly all the 
time that he was doing it … I would have been better if I went to sleep. 
Then you’re not worried about it. (George) 
Every now and then they would move it or wriggle it and you can feel that, 
and it made you want to cough. Yeah. There was no real pain or anything. 
Just really made it cough. They yeah, said a bit more, and a bit more, and 
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another one of these, and another one of them, and away they kept on 
going until I got done. (John) 
Not all participants were disturbed about being aware during the procedure. June found 
that the drugs relaxed her and due to her curious personality she enjoyed the experience. 
She recalled: 
No, I was wide awake the whole time … I could see what was going on, like 
I could—I saw what I thought was a black thing in front of me, just a line. 
But didn’t feel a thing. The only thing that was nasty was the ... down the 
throat (throat spray) … know I was too busy having a little sticky beak. I’m 
shocking … It was just like I was drunk … I felt like I was having a wonderful 
time. (June) 
Just under half the participants had no awareness during the procedure. They were, of 
course, not upset about this experience. Some quotes illustrating this positive experience 
include: 
Once he put the stuff in there, away I went … once they knocked me out 
that was it. (Ian) 
I don’t remember nothing. (Nathan) 
Being aware during the procedure led to negative physical (choking and coughing) and 
psychological (worry about hindering the procedure, information at inappropriate times) 
experiences. However, interactions between participants and staff in the procedure room 
provided participants with some positive experiences. 
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3.7.2.4 Feelings of comfort and safety 
Participants recalled feeling comforted and safe in the procedure room. They believed that 
the staff provided a relaxed atmosphere; they distracted the nervous participants with 
chatter and humour. The participants described feeling safe during the procedure as staff 
displayed their skills and experience. It was also discussed that the participants felt that 
there were enough staff in the procedure room to safely care for them if something went 
wrong. Participants described staff as being helpful, efficient, caring, pleasant and 
comforting. In this way, participants felt they were able to place their bodies into the care of 
the procedure room staff. 
Bit of humour, lighten the mood, I wasn’t so stressed when they started 
talking about different things. One of the nurses, she was talking about 
glasses and that, so just getting your mind off the actual procedure eases it 
as well. (Rachel) 
I was very impressed with … the way they’ve been on the ball. (Alec) 
But you know I didn’t have any problems with—you know the people in 
theatre were very friendly and stuff like that. Everybody knows their job 
and does their job, and very efficient and stuff like that. (Bob) 
I wasn’t worried at all … I know there was a shitload of people there with 
instruments and stuff; I didn’t feel in danger of dying. (Cameron) 
The staff was good down there. (John) 
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They were wonderful, really wonderful. (June) 
I put my life in his hands because he is a terrific man. Terrific doctor … 
(George) 
The number of staff that filled the procedure room was overwhelming at times for one 
participant: 
They’re around you like a mob of flies. You know all over the place … is 
about seven or eight there … well, one was doing this and one was doing 
something else … I probably was a bit anxious I suppose. (George) 
Participants felt that the procedure room was not always pleasant, but was a safe 
environment. They were able to entrust their bodies into the care of the procedure room 
staff. This was due in part to the interactions between the participants and the procedure 
room staff. There were ‘after effects’ of the procedure that included some negative 
experiences. 
3.7.2.5 After effects 
Participants experienced many physical ‘after effects’ of the procedure, including 
headaches, sore throat, coughing, and discomfort. These effects generally did not last more 
than 24 hours. Participants also described factors that may have contributed to these after 
affects: insertion of the instrument in their throat, and flushing of fluid into their lungs, as 
illustrated in the following quotes:  
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I had a stinking headache. But I had a headache before I went in anyway, 
so that’s probably the same. (Bob) 
When I got … home my head was like a pumpkin … I finished up with a 
roaring headache. (George) 
Still a bit sore in the throat. Was pretty sore. (John) 
I’ve got a slight discomfort on the roof of my mouth, from the whatever. 
(Kelly) 
Sore throat was for probably a couple of days. (Rachel) 
I think they flushed my lungs a bit with the camera down there … might 
have shaken … the mucus … to try and get me to bring … (mucus) up and 
out of the lungs … My asthma … for the first 24 hours, it was like a dry 
hacking cough … bit of a sore throat … for probably a couple of days. 
(Rachel) 
Only a bit of chest discomfort, like a bit of … you know sometimes when you 
move the wrong way or breathe. (Bob) 
Probably tired more than anything. (Penny) 
I’ve been drowsy and nodding on and off, but apart from that you know I 
didn’t feel any, I wasn’t feeling weird or anything. (Mark) 
However, not everyone experienced after effects. For example, June said: 
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I felt marvellous. So they said ‘how do you feel?’ I said, ‘Wonderful’. They 
said ‘really’? I said, ‘Yeah’. I said I felt like nothing’s happened. But you 
know I might have been on a high too, who knows? I felt pretty good 
actually. 
Participants frequently discussed the corporeal after effects of the procedure. There were 
the physical effects of headaches, sore throat and aggravation of asthma and the 
psychological effects of anger, resentment and anxiety. There were residual effects of anger 
towards hearing that the physicians were unable to obtain a sample during the procedure 
and anger due to the circumstance where they did not sleep during the procedure. There 
was the ongoing anxiety relating to the procedural results and whether the physician was 
able to get the required specimens during the procedure. Participants also discussed aspects 
within this theme, in relation to their experience, of temporality. For example, participants 
were frustrated when the time for discharge was prolonged, and with the time it was taking 
to garner the procedural results. Participants were also dwelling on the meaning of these 
results in respect of how much time they had to live. These feelings of anxiety and 
frustrations influenced participants’ feelings of acceptance of the phenomenon or resulted 
in dissatisfaction. 
3.7.2.6 Feelings of acceptance or dissatisfaction  
Some participants accepted that the procedure was a necessary experience. Positive 
relationships with the staff, necessity of the procedure, and amnesia during the procedure 
facilitated this notion of acceptance. John was aware during his procedure but Kelly was not. 
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But anyhow, you learn to put up with that (procedures) … they were all 
good down there, all the staff was good down there, they all joked and 
carried on. So … What more could you ask for? (John) 
Well I mean if you’ve got to do it, you’ve got to do it. There’s no point in … 
But the only trepidation of course now, is the results. (Kelly) 
When Bob reflected on his experience of the procedure he was not as positive as John or 
Kelly; he was not happy that he was aware during the procedure. 
I went in there under the thought that I was going to have a biopsy on this 
thing that’s in my lung here or whatever, but they didn’t do a biopsy. So 
now I know they haven’t done a biopsy, whereas I suppose if I was asleep I 
wouldn’t know, I would have been none the wiser until I went on Tuesday. 
So whether that’s good or bad, I don’t know. (Bob) 
George was also vocal about his dissatisfaction regarding the procedure and how it was 
carried out; the fact that he was aware during was also considered a negative experience. 
When I didn’t go to sleep, well I felt that I would have been better if I went 
to sleep. Then you’re not worried about it and you are not … I wanted a bit 
of sleep anyhow. I only had about two and a half hours the night before. 
(George) 
Perceptions of acceptability or dissatisfaction were affected by the participants’ relations 
with healthcare workers during the procedure. Participants were comforted by staff in the 
procedure room. The procedure was a necessity, if the participants wanted a diagnosis and 
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prognosis for their condition. The procedural results were required so that the participants 
could plan for the time they had left to live. When participants were not aware during the 
procedure, their perception of the experience was not coloured by the negative 
consequences of awareness during the procedure.  
3.8 Reflections following second interview 
The data collected were from both the initial interview post procedure and the follow-up 
interview 1-10 days post procedure. Both interviews were unstructured thereby avoiding 
any prompts to confirm previously acquired data. None of the participants changed their 
stories. If a participant was disturbed by the procedure during the first interview then they 
again brought up their concerns in the second interview. Emotions were more muted in the 
second interview for Bob. Bob apologised for being so angry in the initial interview (he was 
angry about not getting a biopsy during his procedure). Consequences of the procedure 
were explored during the second interview. In the second interview Kelly debriefed about 
having to wait a long time before discharge and Rachel talked about having a s ore throat 
and aggravation of her asthma for a couple of days. The second interviews allowed 
confirmation of data collected from the participants ’ first interviews and the collection of 
more data relating to the consequences of the procedure.  
3.9 Summary 
A qualitative study was conducted to investigate experiences of patients who undergo 
bronchoscopy with ‘cautious’ sedation and analgesia. The underlying conceptual framework 
for this study involved a number of interrelating concepts including patient advocacy, 
suffering, the patient’s best interests and current literature, which led the researcher to a 
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design a study that investigated the patient experience of this phenomenon. The research 
design was based on the phenomenological writings of van Manen (1990; 1997; 2014). Data 
was collected from 13 participants. The themes discovered within the participants’ 
interview transcripts were not independent of each other. Themes were teased from the 
data when more than one participant had a similar experience. Each theme gives examples 
of patients’ experiences of this phenomenon. The themes will now be discussed in relation 
to current literature. 
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Chapter Four: Discussion and Conclusions 
4.1 Overview 
The final chapter of this thesis, Chapter Four, presents the discussion of the qualitative 
interview study in relation to the concepts raised in the systematic review. Chapter Four 
also includes the qualitative study limitations and conclusions, and ends with implications 
for future research based on the systematic review and the qualitative study.  
4.2 Discussion 
The conceptual framework for this thesis is based on the interaction of a number of 
concepts that influence the patient experience. The concept of advocacy in connection with 
nursing frameworks is not new. Bramlett, Gueldner & Sowell (1990) discussed the roles of 
various theorists who linked advocacy to nursing frameworks. Advocacy is an ingrained part 
of nursing practice (Barmlett al., 1990) and the underlying motive for conducting this 
investigation. The research candidate has aimed to prevent advocacy and other framework 
concepts (suffering, patients’ best interests, current literature, and hospital policy) from 
influencing the thesis findings. The rigour of the literature review was in part protected by 
the use of Covidence online software, which incorporates Cochrane guidelines for 
systematic reviews. The website ensures that more than one reviewer is involved in the 
selection of studies, evaluating study quality and extraction of data. Phenomenological 
methods and, more specifically, van Manen’s (1984; 1990; 1997; 2014) writings have been 
used to safeguard the data collected in the qualitative study. Van Manen (2014) directed the 
research candidate to abandon her own prejudices that were rooted in her conceptual 
framework and concentrate on the data collected. The qualitative study findings will be 
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compared to current literature so that the themes can be interpreted in the context of prior 
knowledge.  
Bronchoscopy is considered an unpleasant procedure without sedation (British Thoracic 
Society Bronchoscopy Guidelines Committee & Subcommittee of Standards of Care 
Committee of British Thoracic Society, 2001; Gonzalez et al., 2003). In 2001, the British 
Thoracic Society provided guidelines for sedation use in bronchoscopy. This was in response 
to conclusions from randomised controlled trials that measured the patient experience in 
bronchoscopy with sedation. The reports indicated that the negative symptoms associated 
with bronchoscopy decreased with sedation (Crawford, Pollock, Anderson, Glavin, 
Macintyre & Vernon, 1993; Maltais, Laberge & Laviolette, 1996; Rees, Hay & Webb, 1983). 
Other thoracic societies followed suit in Australia and New Zealand (Wood-Baker et al., 
2001), Israel (Shulimzon, 2010) and America (Wahidi et al., 2011). Recent surveys in 
Australia and New Zealand, Switzerland, and Spain reported that sedation during 
bronchoscopy is routinely used in most of the hospitals (Gaisl et al., 2016; Salgado et al., 
2015). Eighty-eight percent of patients having flexible bronchoscopies in Germany are 
sedated (Hautmann et al., 2016), however patients are still having bronchoscopy without 
sedation. The most recent survey from the United Kingdom was conducted by Smyth & 
Stead (2002). They found that 63% of physicians sedated patients and 14% administered 
analgesia. The most recent survey in Japan found that 36% of physicians provided sedation 
(Asano et al., 2012).  
The study conducted for this thesis used a sample of patients who had COPD and 
underwent fibreoptic bronchoscopy. The participants were given cautious sedation and 
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analgesia. Data were collected via unstructured interviews to reduce bias in data collection 
and were analysed with phenomenological methods based on the writings of van Manen 
(1990; 2014). The study participants recalled many experiences of the phenomenon. 
Psychological experiences included distress, anxiety and frustration. Physical experiences 
included coughing, breathlessness, choking, sore throat and headache. Often, participants 
were satisfied with their experience but, due to awareness during the procedure and 
feelings of neglect post-procedure, some participants were dissatisfied. Some aspects of 
these experiences have been measured in bronchoscopy studies previously. Studies have 
asked patients to measure aspects of their psychological and physical experience plus their 
overall satisfaction in regard to the experience.  
The patient self-reported outcomes that have been used previously to measure the 
psychological impact of bronchoscopy include amnesia, distress and intolerance. In the 
current literature concerning patient experience in bronchoscopy, these psychological 
outcomes were often more adverse when lower levels of sedation were administered 
during the procedure (Cases Viedma et al., 2010; Gonzalez et al., 2003; Lo et al., 2011; 
Hwang et al., 2005; Schwarz et al., 2007; Silvestri et al., 2009). Cases Viedma et al. (2010) 
and Gonzalez et al. (2003) found that sedation versus a placebo resulted in greater amnesia 
and less negative physical experiences. Unfavourable psychological outcomes were reduced 
when midazolam or nitrous oxide were given to patients during bronchoscopy compared to 
administration of a placebo (Atassi et al., 2005; Cases Viedma et al. 2010). Patients reported 
these negative experiences less when they underwent the procedure with propofol rather 
than midazolam (Clark et al., 2009), or when propofol and ketamine were administered 
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versus propofol and alfentanil (Hwang et al., 2005). Not all studies concerning patient 
experience in bronchoscopy asked patients to report on psychological outcome measures.   
Cases Viedema et al. (2010) found that patients who had sedation in bronchoscopy were 
more likely to have amnesia. Just under half of the qualitative study participants had 
amnesia. The lack of amnesia often resulted in negative experiences. One participant was 
upset when he heard information from the doctors at an inappropriate time. If the patient 
had amnesia, then this distress could have been avoided. Other experiences that caused 
distress were largely related to physical experiences including throat spray, coughing and 
choking, headaches, sore throat and aggravation of asthma.  
The anxiety of the participants in this study was triggered by fear that the procedure would 
be uncomfortable and, in some cases, the fear that if they coughed the doctor would not 
obtain the required specimens for their diagnosis and prognosis. Poi, Chuah, Sirinivas & 
Liam (1998) performed a mixed methods study to elicit patients’ fears before bronchoscopy. 
They found that the most common fear was that the procedure would be painful. This fear 
may be unfounded in respect to the qualitative study conducted in this thesis as none of the 
participants said that the procedure was hurtful; they often said it did not hurt. Poi et al. 
(1998) reported other common fears including breathing difficulties, irritation in the throat, 
bronchoscopy findings, sedation, and local spray. They found that the doctors tended to tell 
patients why they were performing the procedure but not how, recommending that written 
information for patients should be provided, listing the sensations that they are likely to 
experience. In this research, the study participants recalled not knowing enough about how 
the procedure would affect them. The literature that participants received prior to the 
                               
 
– 93 – 
 
procedure described how the procedure would be performed, but not how it would make 
them feel. The education that the physician gave the participants before the procedure was 
not explored as a component of this thesis.  
Most of the participants in this study had been informed that they may have lung cancer 
prior to being given information and instructions about the bronchoscopy. Results of 
cognitive-psychological experiments have reported that a patient’s recall of medical 
information after being given bad news is reduced (Kessels, 2003). Kessels (2003) and van 
Osch, Sep, van Vliet, van Dulmen and Bensing (2014) make suggestions to improve patient 
recall after the delivery of bad news. They suggest that the person delivering the patient 
education needs to consider first the patient’s emotional needs, then provide simple and 
specific instructions with supportive written and visual documentation. Although the 
participants of this study were scared before the procedure, this was often reduced once 
they arrived in the procedure room. The study participants found that the presence of a 
large—perceived as competent—health care team that was humorous and relaxed reduced 
their anxiety. Humour is known to reduce stress and increase a person’s ability to cope 
(Tremayne, 2014).  
Another common cause of anxiety for the qualitative study participants was the fear that 
they had lung cancer and may receive a poor prognosis. This was found to be a fear in a 
previous study that explored patient fears prior to bronchoscopy (Poi et al., 1998). The 
review of the associated literature identified a communication technique, referred to as 
affective communication, to manage this fear (van Osch et al., 2014). This technique 
includes asking the patient what they fear, listening to their fears, exploring the validity of 
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these fears and then explaining how they will be supported. The findings of the qualitative 
study have increased awareness regarding bronchoscopy patient fears. Recommendations 
to reduce these fears include strategising patient education pre-bronchoscopy, including 
asking patients about their fears, discussing their fears, informing them of when they would 
receive the results from their procedure, and describing how they will be supported during 
and post-procedure.   
Frustration was not an outcome measured in any of the quantitative studies in 
bronchoscopy. However, it was identified on the current qualitative study where 
participants’ feelings of frustration were found to be related to hospital policies and 
procedures, namely large amounts of documentation, long fasting and waiting times. 
Paperwork is a requirement for patient safety and quality care, but the administrative 
burden can shift the focus from the patient care to paperwork (American Hospital 
Association, 2006). Fasting times were not measured in this study, but it is apparent that 
some participants fasted in excess of the current recommendations. Fasting is required prior 
to a bronchoscopy to prevent aspiration of food or fluids into the lungs (Ignatavicius, 
Workman & Winkelmann, 2014). Recommendations for fasting before bronchoscopy are 
four hours for food and two hours for clear fluids (Shulimzon, 2010; Du Rand et al. 2013). 
Research has reported that fasting procedures lower blood sugar levels, which can be 
associated with higher levels of aggression in frustrating situations (DeWall, Deckman, 
Gailliot & Bushman, 2011). Waiting time is not a new cause of frustration in the hospital 
system; a systematic review of patient satisfaction in emergency departments found that 
waiting time was one of the predictors of in-patient dissatisfaction (Boudreaux & O’Hea, 
2004). Van Manen (1990) suggests that experiences of time seem to speed up when people 
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enjoy the experience and slow down when they do not (van Manen, 1990). He also suggests 
that experiences of waiting can feel extended due to inactivity during this time (van Manen, 
2014). Those who participated in the qualitative study did not describe the environment for 
which they waited prior to their procedure, other than they thought that it was a busy 
space. However, they did discuss how they dwelt on their fears during this waiting time. 
Given that they had time to dwell on their fears, it is possible that they were physically 
inactive during this time, potentially increasing their perception of longevity during the 
waiting period.  
The literature review found that when patient experiences in bronchoscopy were measured, 
the main physical outcomes measured were pain and cough. The participants’ ratings of 
pain and cough were reduced with greater amounts of sedation and the addition of 
analgesia (Atassi et al., 2005; Cases Viedma et al., 2010; Gonzalez et al., 2003; Schlatter et 
al., 2011; Silverstri et al., 2009). Unfortunately, other physical impacts of the procedure 
were not consistently or were rarely measured, such as breathlessness and choking, but 
when used, participants generally rated them lower when they were given more sedation 
(Cases Viedma et al., 2010; Clark et al., 2009; Gonzalez et al., 2003; Rolo et al., 2012; Lo et 
al., 2011). Bronchoscopy patient perceptions of comfort during the procedure have been 
identified as independent of their perceptions of cough and breathlessness during a study 
conducted by Lo et al. (2011). This study compared two drug regimens: i) the treatment 
group received propofol and alfentanil; and ii) the control group received midazolam and 
alfentanil. The researchers asked their subjects to rate their tolerance of the procedure, 
experience of cough, breathlessness, and comfort. They found that the treatment group 
rated their tolerance significantly higher than the control group, and rated their experiences 
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of cough and breathlessness significantly lower than the control group, but there was no 
significant difference between the group’s ratings of comfort. This may be explained by the 
fact that both groups received a pharmaceutical drug relief (alfentanil) as part of the drug 
regime. 
In the current qualitative study, participants experienced coughing and choking because of 
the throat spray, automatic reflexes, and awareness of the passage of the bronchoscope in 
their lungs during the procedure. Participants’ descriptions of the throat spray included 
distaste, throat swelling, choking, and difficulty swallowing. Discomfort related to the throat 
spray in bronchoscopy was measured by Lo et al. (2011) and Contoli et al. (2013). Lo et al. 
(2011) found that there was no significant difference in discomfort from throat spray when 
patients who had propofol were compared to patients who had midazolam. It is unclear 
from the Lo et al. (2011) study whether the patient’s throat was sprayed with local 
anaesthetic before or after sedation was administered. Contoli et al. (2013) also measured 
patient experience of the throat spray but the results were not reported, as the experience 
was measured as part of an overall tool to measure patient tolerance of the procedure. 
Some qualitative study participants described throat swelling after their throat was sprayed 
pre-procedure. This is not a new finding. One study found that a significant number of 
patients with asthma have airway constriction after throat spray (McAlpine & Thomson 
1989).  
The patient experience of coughing and choking has been measured in quantitative 
bronchoscopy studies: patient ratings of coughing and choking decrease with increased 
sedation. To the research candidate’s knowledge, the effects of coughing and choking on 
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the patient have not been explored until this thesis. Coughing and choking caused the 
qualitative study participants distress and fear. The participants feared that they were 
making the procedure difficult for the staff and as a consequence they may not obtain the 
specimens for the procedural diagnosis. The qualitative study participants recalled 
breathlessness as a post-procedure experience, but no participants mentioned that they 
were short of breath during the procedure. Lo et al. (2011) asked their subjects to rate their 
breathlessness during bronchoscopy. Their study compared patients’ experience of 
bronchoscopy with propofol or midazolam. They found that the midazolam group had 
significantly higher ratings of breathlessness. Amnesia was not measured in this study. 
No qualitative study participants described experiences of nausea. The only study on the 
subject of bronchoscopy that measured patient experience of nausea in bronchoscopy was 
by Rolo et al. (2012). They compared the use of midazolam as a sedative with a placebo. 
They found no significant difference in patient ratings of nausea between these groups. 
None of the qualitative study participants recalled the procedure as being painful. 
Participants did describe some experiences that they thought were uncomfortable; these 
included coughing and choking. They described headaches and sore throat as post-
procedure discomfort.  
Qualitative study interviews were unstructured, thereby not allowing direct questioning 
regarding pain. The review of current literature found that pain was the most common 
outcome measured to reflect patient experience in bronchoscopy. In these studies, subjects 
rated their levels of pain lower when they were given sedation (Cases Viedma et al., 2010; 
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Gonalez et al., 2003; Schlatter et al., 2011; Schwarz et al., 2007). More research is required 
to determine why participants would find the procedure painful. 
Some participants of the qualitative study accepted that the bronchoscopy experience was 
necessary. They described an overwhelming desire to find a diagnosis and prognosis for 
their condition. The positive relations with the staff in the procedure room may have 
influenced their ability to accept the procedure and the negative experiences. Unclear 
satisfaction and dissatisfaction were related to participants’ awareness during the 
procedure. There have been some studies that have measured patients’ degree of 
awareness during bronchoscopy (Silvestri et al., 2009; Cases Viedma et al., 2010), but its 
impact on the patient’s experience has not been explored previously. While awareness and 
potential distress may be alleviated with greater levels of sedation, this may increase the 
risk of complications. Risks may be reduced with the choice of sedation. Propofol provides a 
higher quality of sedation than midazolam (Clark et al., 2009) and due to its short half-life 
and rapid action it is often the drug of choice for older patients with COPD (Gruber & 
Tschernko, 2003). In a recent study by Stolz et al. (2004). It was reported that the use of 
propofol was relatively safe in high-risk respiratory patients with only minor adverse events 
(hypotension and oxygen desaturation). Propofol may have some benefits but its use is 
limited to the presence of an anaesthetist, which increases the overall cost of the 
procedure. 
4.3 Limitations 
In this qualitative study, limitations included not observing the participants’ bronchoscopies. 
Observation notes from an independent researcher of the participant procedures could 
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have validated participants’ stories and determined if amnesic participants exhibited signs 
of suffering or distress during the procedure. Also, interviewing participants pre-procedure 
may have increased the richness of the data. When participants were interviewed post-
procedure, their recollections may have been colored by their immediate concerns of the 
impending diagnostic results. The study provides examples of patient experiences in this 
procedure and can only be used for theoretical generalisation. It is also important to 
acknowledge that the research candidate’s past observations of patient distress while 
undergoing bronchoscopy may have colored the research. To limit this, the research 
candidate conducted unstructured interviews (reducing the risk of leading questions) and 
rejected her own prejudices and theories to concentrate on the real data, as this was more 
significant (van Manen, 1984; 2014).  
4.4 Conclusions 
Patient experience during bronchoscopy is relatively unexplored. The literature review in 
this thesis found no qualitative studies exploring the subject. The current literature is 
quantitative and is focused on measurement of aspects of the patient experience: most 
commonly, patients were asked to express their perceived experience of pain, cough and 
willingness to repeat the procedure on various scales or with dichotomous questions. These 
scales or questions have been used to compare the patients’ negative experiences when 
undergoing the procedure with different treatment regimens. It has been identified that 
when the patient is sedated there are significantly less negative experiences for the 
patients. The qualitative study presented in this thesis confirmed that some patients who 
undergo bronchoscopy encounter negative experiences. Patients experienced common 
fears, for example, the throat spray was unpleasant, consequences of awareness were 
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significant, common consequences of the procedure were identified, and some participants 
accepted the negative experiences in order to obtain a diagnosis.   
The qualitative study demonstrated that some patients are aware during bronchoscopy 
when cautious sedation and analgesia were used, and may have full recollection of the 
procedure with its attendant discomforts. Participants remembered coughing and choking 
and the ensuing feelings of distress. The qualitative study also found that awareness during 
the procedure could lead to the disclosure of information to the patient at an inappropriate 
time, such as difficulties associated with the procedure, obtaining a biopsy, or diagnostic 
outcomes. Specific to the setting, this study uncovered issues regarding repetitive and 
lengthy documentation procedures, and unnecessarily long fasting and waiting times. These 
are amenable to improvement. As explored in previous studies, it was confirmed that 
patient fear was a problem before bronchoscopy and it was discovered that little attention 
was accorded to participants’ potential experience of the bronchoscopy and how it might 
feel. However, despite their negative experiences, participants were accepting of their 
experience, considering it a ‘necessary evil’ in order to obtain a diagnosis. 
4.5 Implications for practice 
The implications of this qualitative study include providing new findings and 
recommendations for practice. This thesis has provided a definition of ‘cautious’ sedation 
and analgesia that may be used in relation to bronchoscopy procedures and further 
research in this area. The qualitative data and analysis explored the patient’s experiences 
during bronchoscopy. The resulting findings could increase health care workers’ empathy. 
The discussion of these findings in comparison to current literature may influence practice. 
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As revealed in this study, patients sometimes have fears prior to their procedure, which may 
be caused by inadequate patient education. The patients often fear that they have a life-
threatening diagnosis. Patients may be aware during the procedure and may be able to 
recall what is discussed. They may recall the presence of the bronchoscope in their throat 
and their bodies’ unconscious responses of coughing and/or choking. They may also 
remember worrying that their coughing and choking could make it more difficult for the 
physician and as a consequence the physician may not be unable to obtain the specimens 
required for their diagnosis. Common consequences of the procedure are sore throat, 
coughing and headaches. Patients may also feel neglected, if they wait too long for service. 
The associated literature provides suggestions to ameliorate some of the problems that are 
faced when a patient undergoes bronchoscopy with cautious sedation and analgesia. Poi et 
al. (1998) discuss educating patients on how the procedure will make them feel, not only 
how it will be performed. Van Osch et al. (2014) discuss using affective communication 
techniques to manage patients’ fears when they have been given bad news. Stolz et al. 
(2004) suggest the use of propofol as a sedative in cases where the patient has COPD, as the 
drug has a short half-life and can reduce patient awareness. Unfortunately, the use of 
propofol is limited due to greater financial and employment burdens.  
The findings of this study could also be used as the basis for a tool to measure patient 
experience in bronchoscopy in future research.  
4.6 Future research 
This thesis has explored patients’ experiences of bronchoscopy. A literature review was 
performed and studies were retrieved and evaluated that measured various aspects of 
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patient experience during bronchoscopy. The qualitative study explored in-depth the 
experiences of COPD patients who had the procedure. However, the scope of this research 
can be expanded, and this section presents some future research directions.  
The literature review could be upgraded to a systematic review with meta-analysis. There 
are two systematic reviews that include the subject of patient experience in bronchoscopy. 
These reviews restrict their review of patient experience to pain, coughing and patient 
willingness to repeat the procedure. A meta-analysis of awareness, choking and 
breathlessness would be difficult due to the limited number of studies that have measured 
these physical aspects of patient experience during bronchoscopy but a description of these 
findings may alert procedural staff to these unexplored areas of patient experience. The 
development and psychometric evaluation of a tool to measure the patient experience in 
bronchoscopy based on the findings from this review and qualitative study may be 
beneficial for future research. Currently, outcomes and scales used to measure patient 
experience in bronchoscopy are numerous and varied, and not based on published 
qualitative studies. The outcomes and scales used are not consistent across studies and do 
not always measure awareness during the procedure, which, as the qualitative study has 
described, has both physical and psychological implications  post-procedure. To ensure a 
robust psychometric validation of this tool, a multicentre mixed-method study could be 
performed.  
A prospective multi-centre mixed methods study of patient experience in bronchoscopy that 
does not limit the participants to those with high-risk respiratory disease could lead to a 
broader understanding of the patient experience in bronchoscopy. An exploration of the 
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patient experience of the phenomenon in relation to the incidence of longer and more 
difficult procedures may provide data that could positively influence management of patient 
sedation. Action-research studies may be appropriate to assist in ameliorating specific 
study-site problems as the conclusions drawn in these studies are data-based that usually 
draw the data from multiple sources. Site problems include unclear explanation of 
procedure to patients, excessive paper work, and waiting and fasting times. With action 
research, the conclusions emerge slowly over the course of the study as researchers 
challenge emerging conclusions by pursuing disconfirming evidence.  
Another suggestion for further research is an exploration of the problems related to the 
dissemination of qualitative study findings. It has been observed that clinicians tend to have 
a greater confidence in quantitative rather than qualitative research. Exploration of local 
physicians’ responses to the qualitative findings may facilitate the process of disseminating 
the study’s findings outside the local facility and thereby influence embedded views of 
internal and external treating physicians. Another study may be required that combines 
collection of qualitative and quantitative data to satisfy the physicians ’ desire for 
quantifiable clinical evidence.  
An underlying reason for conducting this study was to verify the nurse’s perceptions that 
many patients were consciously not tolerating the procedure. The nurses wanted to 
advocate for their patients; nurses at the site of the study alerted the research candidate 
that patients may be aware and negatively affected by the procedure. It was unclear if the 
patients’ reactions were conscious or unconscious. Within the literature on the subject of 
bronchoscopy, there have been studies where midazolam has been given for sedation 
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during bronchoscopy (Cases Viedma et al., 2010). These studies have concluded that 
patients have been willing to repeat this procedure when given midazolam for sedation. 
From the data collected in this qualitative study, some participants were consciously not 
tolerating the procedure. It is unclear if the participants who had no recollection of the 
procedure displayed behaviours of procedure intolerance. Exploring the match between 
nurses’ experience and patients’ experience may increase understanding of the nursing and 
patient relationship during this phenomenon.  
In summary, the aim of future research in this area needs to be focused on broadening the 
exploration of the patient experience in bronchoscopy. This would involve the development 
and psychometric evaluation of a tool to measure patient experience in bronchoscopy that 
would enable systematic comparison and assessment of various  interventions that have the 
potential to improve the patient experience during bronchoscopy. In addition, novel 
strategies should be explored in regard to dissemination and translation of this new 
information to reach both practice and policy. 
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Appendix 1 
This appendix includes a published study protocol for a systematic review on the subject of 
patient experience in bronchoscopy with or without various pharmaceutical agents. 
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